case_id,mode,case_type,iteration,Q0_answer,Q0_reasoning,Q1_answer,Q1_reasoning,Q2_answer,Q2_reasoning,Q3_answer,Q3_reasoning,Q4_answer,Q4_reasoning,Q5_answer,Q5_reasoning,Q6_answer,Q6_reasoning,Q7_answer,Q7_reasoning,Q8_answer,Q8_reasoning,input_tokens,output_tokens,total_tokens
Case3223,baseline,without_policy,iter3,BRCA1/2,The referral explicitly states BRCA1 and BRCA2 testing is requested (patient referred for BRCA1 and BRCA2 testing).,Not Specified,BCBS_FEP BRCA coverage is based on personal/family history criteria rather than strict age cutoffs; no age-based exclusion applies in this clinical scenario (patient is 75) per payer criteria.,Not Specified,"BCBS_FEP does not impose a narrow specialty restriction for ordering BRCA testing in the typical policy language; a referring physician (general practitioner) can order testing. The record shows a GP referral, but the policy does not specify a special ordering-provider requirement.",Yes,"BCBS_FEP coverage criteria approve BRCA testing for unaffected individuals with a first-degree relative with epithelial ovarian cancer. The patient has a sister with epithelial ovarian cancer (first-degree), meeting a medical/family-history indication.",Not Specified,The BCBS_FEP BRCA policy does not require completion of other genetic tests prior to BRCA1/2 testing in this scenario; the prior CMA for a congenital cardiac anomaly is unrelated and not a required prior test.,Yes,"Family-history criteria are relevant for BRCA testing and the patient has a first-degree relative (sister) with epithelial ovarian cancer, which is a specified relevant family history per payer criteria.",No,"BCBS_FEP typically requires documentation of pre-test genetic counseling for BRCA testing. The record states there is no documentation of pre-test genetic counseling, so counseling requirements are not met.",81162,"Among the provided CPT options, 81162 corresponds to full BRCA1/BRCA2 analysis (combined BRCA1/2 testing) used for hereditary breast/ovarian cancer testing.",No,"Although the patient meets clinical/family-history criteria for BRCA1/2 testing (first-degree relative with ovarian cancer), BCBS_FEP requires documented pre-test genetic counseling. Because no pre-test counseling is documented, coverage criteria are not fully met and the claim would not meet payer requirements.",1963,1997,3960
Case14226,baseline,without_policy,iter3,BRCA1/2,The clinical note explicitly states germline BRCA1 and BRCA2 (BRCA1/2) testing is being ordered.,Not Specified,Cigna's BRCA testing policy does not impose a specific age cutoff for testing; the patient is 55 but no age-based exclusion or requirement is specified in the policy.,Not Specified,"Cigna policy does not mandate a specific ordering provider specialty (e.g., only geneticist); while counseling documentation may be required, a specific ordering-provider type is not specified in the policy information provided.",No,"Cigna's BRCA coverage requires either a qualifying personal cancer history (e.g., breast, ovarian, pancreatic, metastatic prostate, etc.) or an elevated calculated mutation probability per accepted models. This patient has a nonspecific primary solid tumor (not a listed BRCA-associated tumor) and a calculated BRCA pathogenic-variant likelihood of 2.5%, which does not meet Cigna's calculator threshold (policy requires a higher probability—e.g., ≥3% or other stated threshold). Therefore the medical indication criteria are not met.",Not Specified,Cigna's BRCA policy does not require prior genetic testing (other than documentation of family/personal history or risk calculation); no specific prior test completion is mandated in the provided policy context.,No,"Cigna's eligibility includes relevant family history of BRCA-associated cancers. The only family history reported is a mother with a severe hematologic/immunologic disorder, which is not a BRCA-associated cancer, so family-history criteria are not met.",No,"Cigna requires documentation of informed pre-test genetic counseling for BRCA testing; the record states no pre-test genetic counseling was completed, so counseling requirements are not satisfied.",81228,"Of the provided CPT options, 81228 is the code that corresponds to BRCA1/BRCA2 sequence analysis (best match for BRCA1/2 germline testing among the listed choices).",No,"Per Cigna coverage criteria, the patient does not meet medical indication (personal cancer type not clearly BRCA-associated and calculated mutation probability 2.5% below policy threshold) and pre-test genetic counseling is not documented. Based on these unmet criteria, BRCA1/2 testing is not covered.",2026,2302,4328
Case10451,baseline,without_policy,iter3,WES,The clinical note explicitly states neurology referred the patient for whole exome sequencing (WES) to evaluate an unexplained neurodevelopmental disorder.,Not Specified,UHC WES coverage criteria do not impose a strict age cutoff for exome sequencing; pediatric onset neurodevelopmental disorders are routinely covered but a specific numeric age criterion is not defined.,Not Specified,"UHC policy requires an appropriate ordering clinician, but it does not narrowly restrict orders to only geneticists in all cases; a treating specialist (neurology) commonly meets ordering-provider expectations and the record shows a neurologist placed the order.",Yes,"UHC coverage for WES includes unexplained moderate-to-severe intellectual disability/neurodevelopmental disorder; the patient is a child with moderate–severe intellectual disability and an unexplained neurodevelopmental condition, meeting the medical indication.",Not Answerable,"UHC requires prior relevant testing (notably chromosomal microarray) before WES; CMA was performed and nondiagnostic. However some criteria also require targeted testing such as FMR1 (Fragile X) in males with ID — the patient’s sex is not provided, so completion of all condition-dependent prior tests cannot be determined from the record.",Not Specified,UHC WES criteria do not require a specific positive family history or consanguinity for coverage of WES; the sibling’s brief resolved unexplained event is noted but not a specified family-history requirement in the policy.,No,"UHC generally requires documentation of pre- and/or post-test genetic counseling for clinical WES; there is no documentation of genetic counseling in the record, so counseling requirements are not met.",81415,CPT 81415 corresponds to clinical whole exome sequencing (WES) and is the appropriate code for the ordered test.,No,"Although the patient meets the clinical indication for WES and prior CMA was nondiagnostic, required pre-test genetic counseling is not documented (and some sex-dependent prior testing such as FMR1 may be required). Per UHC policy, lack of required counseling (and any missing condition-dependent prior tests) would prevent approval until documentation is provided.",1999,2659,4658
Case4196,baseline,without_policy,iter3,WES,The patient information explicitly states whole exome sequencing (WES) is being requested as the next diagnostic step.,Yes,"BCBS FEP WES coverage for unexplained developmental delay/intellectual disability applies to pediatric patients; there is no restrictive upper/lower age exclusion for a 10‑year‑old, so the patient's age (10) meets age-based eligibility.",Not Specified,"BCBS FEP WES policy emphasizes appropriate genetic counseling/interpretation but does not mandate a single specific ordering provider specialty in all cases; the chart documents pre‑test genetic counseling, but the policy does not explicitly require the ordering clinician to be a specified specialty in the provided facts.",Yes,"BCBS FEP coverage criteria list unexplained developmental delay/intellectual disability as an indication for WES. The patient has nonsyndromic developmental delay and intellectual disability, meeting that clinical indication.",No,"BCBS FEP generally requires prior first‑tier testing (chromosomal microarray and targeted tests such as Fragile X in males) before WES for unexplained ID/DD. Only FISH (targeted) was performed and was nondiagnostic; there is no documentation of prior chromosomal microarray or Fragile X testing, so required prior testing has not been completed.",Yes,The patient has a relevant family history (a brother with childhood moderate–severe intellectual disability). BCBS FEP criteria consider positive family history relevant to testing decisions.,Yes,"BCBS FEP requires documentation of pre‑test genetic counseling for WES; the record notes pre‑test genetic counseling was completed with planned post‑test follow‑up, satisfying counseling requirements.",81415,CPT 81415 corresponds to clinical whole exome sequencing (proband or diagnostic WES) and is the appropriate code for the requested WES.,No,"Although the patient meets the clinical indication, age, counseling, and has supportive family history, BCBS FEP requires completion of first‑tier testing (e.g., chromosomal microarray and Fragile X testing where applicable) before approving WES. Those prior tests are not documented (only nondiagnostic FISH), so coverage is not met at this time.",1997,1770,3767
Case18281,baseline,without_policy,iter3,WGS,The cardiologist explicitly ordered whole genome sequencing (WGS) for this child with multiple congenital anomalies.,Yes,UHC genomic-sequencing coverage is directed at pediatric patients with congenital anomalies/developmental concerns; the patient is 6 years old and therefore meets age-based pediatric criteria.,Not Specified,"UHC policies focus on clinical indications and requirements for genetic counseling/prior testing; they generally allow treating specialists to order testing, but a strict single-provider-type requirement is not specified in the provided patient data.",Yes,"UHC covers WGS/WES for children with multiple congenital anomalies or unexplained syndromic presentations; the patient has multiple congenital anomalies that do not fit a well-delineated syndrome, which meets medical-necessity criteria.",No,UHC typically requires prior relevant testing (commonly chromosomal microarray and other targeted testing) before WGS/WES; only Fragile X testing is documented (nondiagnostic) and chromosomal microarray is not documented as completed.,Yes,"There is a documented family history of an inborn error of metabolism in a sibling, which is relevant family-history information for genomic testing eligibility/interpretation.",No,UHC policies require documentation of pre-test genetic counseling or informed consent by a qualified provider for WGS/WES; the record states no genetic counseling was conducted prior to testing.,81425,CPT 81425 corresponds to whole genome sequencing; this best matches the ordered test (WGS).,No,"Although age and clinical indication are met, required prior testing (e.g., chromosomal microarray) is not documented and pre-test genetic counseling was not done—UHC coverage typically requires those elements, so coverage would be denied.",1982,1741,3723
Case17196,baseline,without_policy,iter3,CMA,The clinical note explicitly states the oncologist referred the patient for chromosomal microarray (CMA) testing.,Not Specified,BCBS FEP CMA coverage criteria do not impose a strict age cutoff; the patient is 63 but age-based eligibility is not specified in the policy for CMA.,Not Specified,BCBS FEP CMA policy does not mandate a specific ordering provider specialty in its stated eligibility rules; the referral is from an oncologist but provider-type requirements are not specified.,No,"BCBS FEP generally covers CMA for individuals with unexplained developmental delay/intellectual disability, autism spectrum disorder, or multiple congenital anomalies. This patient’s presentation is longstanding psychiatric (bipolar/schizophrenia/OCD features) without documentation of developmental delay, intellectual disability, or congenital anomalies, so he does not meet the specified medical indications.",Not Specified,"BCBS FEP coverage for CMA does not universally require specific prior testing (karyotype is not a required prior test in the policy); although a karyotype was performed and nondiagnostic, the policy does not list prior-test prerequisites.",Not Specified,"The patient has a sibling with early hearing/visual impairment, but BCBS FEP CMA criteria do not explicitly require or define family-history/consanguinity conditions as standalone eligibility—family history is not specified as a primary criterion in the policy.",Not Specified,"BCBS FEP CMA policy does not explicitly require documented pre-test genetic counseling as a hard eligibility criterion in the coverage rules provided; although no pre-test counseling was done, counseling requirements are not specified for CMA in the policy.",Not Specified,None of the listed CPT codes correspond to chromosomal microarray (CMA) testing; therefore a matching CPT from the provided options is not specified.,No,"Applying BCBS FEP coverage criteria: CMA is covered for unexplained developmental delay/intellectual disability, autism, or multiple congenital anomalies. This patient’s documented problem is psychiatric (bipolar/schizophrenia/OCD features) without documented developmental delay, intellectual disability, or congenital anomalies; prior karyotype nondiagnostic does not change indication. Therefore the requested CMA does not meet BCBS FEP medical necessity criteria and is not covered.",1992,2231,4223
Case8288,baseline,without_policy,iter3,WES,The clinical note states whole exome sequencing is being pursued after a nondiagnostic CMA for a fetal major cardiac malformation.,Not Specified,"UHC WES policy does not impose a strict age cutoff; prenatal/fetal indications are covered under clinical criteria, so age-based eligibility is not specified.",Yes,"UHC requires an appropriate ordering clinician and documentation of genetic evaluation/counseling. The case was referred for genetic evaluation by a developmental pediatrician and parents had multiple genetic counseling sessions, satisfying ordering/provider requirements.",Yes,UHC criteria consider WES medically necessary for a fetus with major congenital anomaly when first‑line testing (CMA) is nondiagnostic; this fetal major cardiac anomaly with nondiagnostic CMA meets that indication.,Yes,UHC WES coverage requires prior appropriate testing (chromosomal microarray) for congenital anomalies; the record states CMA was previously performed and nondiagnostic.,Yes,"There is a documented family history (older sibling with an inborn error of metabolism), which is relevant to genetic evaluation and supports testing per UHC criteria.",Yes,"UHC requires documentation of pre‑test genetic counseling for WES; the parents have had multiple sessions with a genetic counselor, meeting counseling requirements.",81415,CPT code 81415 corresponds to clinical whole exome sequencing (WES) and is the appropriate code for the requested test.,Yes,"Under UHC policy, WES is covered for a fetus with a major structural anomaly when CMA is nondiagnostic and appropriate counseling/ordering clinician documentation exists; all these conditions are met in the provided information.",2018,1905,3923
Case3422,baseline,without_policy,iter3,WES,Patient is explicitly being considered for whole‑exome sequencing (WES) per the clinical note.,Not Specified,Cigna WES coverage is indication‑based rather than age‑restricted; no age‑based exclusion or specific age criteria are applicable to this adult (34 y/o) in the policy.,Not Specified,"Cigna policy requires appropriate clinical documentation and genetic counseling but does not mandate a single specific ordering specialty in this case; the record shows referral by oncology and multiple genetic counseling visits, but no explicit ordering‑provider restriction is documented.",Yes,"Cigna covers WES for suspected genetic disorders presenting with congenital anomalies after prior testing is nondiagnostic. The patient has congenital choanal atresia and a nondiagnostic CMA, meeting the medical‑necessity indication for WES.",Yes,"Cigna generally requires prior chromosomal microarray (CMA) for congenital anomalies before WES; the patient had a nondiagnostic CMA, satisfying the prior‑test requirement.",Not Specified,"While family history can be relevant, Cigna's primary WES criteria focus on the proband's phenotype and prior testing; the provided family history (mother with breast cancer at 50) is not a specified criterion for WES for choanal atresia in the policy.",Yes,"Cigna requires documentation of pre‑test genetic counseling for WES; the patient has seen a genetic counselor multiple times, meeting counseling requirements.",81415,CPT 81415 corresponds to clinical whole‑exome sequencing (proband or trio reporting); this best matches the requested WES.,Yes,"Based on Cigna criteria: patient has a congenital anomaly (choanal atresia), prior nondiagnostic CMA, documented genetic counseling, and clinical suspicion of a genetic etiology — together these meet Cigna's coverage requirements for WES.",1964,1829,3793
Case5885,baseline,without_policy,iter3,WGS,The patient information explicitly states 'whole genome sequencing (WGS) is requested.',Yes,UHC WGS/WES policies apply primarily to pediatric patients with suspected genetic disorders; the patient is 11 years old (pediatric) and therefore meets age-based eligibility under the payer's pediatric testing criteria.,Yes,"UHC typically requires appropriate specialist involvement and documentation of genetic counseling; the referral was from neurology with pre-test counseling discussed with a genetic specialist, satisfying ordering/provider requirements.",No,"UHC coverage criteria for WGS usually require multiple congenital anomalies affecting two or more organ systems, significant neurodevelopmental disorder, or other defined clinical indications. The record documents a 'major abnormality affecting at least one organ system' without meeting the multi-system or neurodevelopmental criteria, so medical-necessity criteria are not met.",No,"UHC often requires prior appropriate testing (e.g., chromosomal microarray and/or targeted panels) before WGS. Only Fragile X testing (nondiagnostic) is documented; no CMA or other required prior tests are documented.",Yes,The patient has a family history relevant to genetic evaluation (mother with long QT syndrome). UHC accepts pertinent family history as relevant supporting information for genetic testing eligibility.,Yes,UHC requires documented pre-test genetic counseling and post-test plans for high-complexity testing; the note states pre-test counseling was discussed with a genetic specialist and post-test follow-up plans are in place.,81425,"CPT 81425 corresponds to whole genome sequencing with interpretation and report, which matches the requested WGS.",No,"Despite appropriate age, provider involvement, documented genetic counseling, and relevant family history, the request fails payer medical-necessity requirements (no multi‑system congenital findings or defined indication) and required prior testing (e.g., CMA) is not documented; therefore coverage is not supported under UHC criteria.",1975,1585,3560
Case14195,baseline,without_policy,iter3,BRCA1/2,The patient was specifically referred for BRCA1/2 testing per the clinical information.,Yes,BCBS_FEP BRCA policies apply to adults; the patient is 18 years old and therefore meets the typical age threshold for adult predictive/testing under the payer policy.,Yes,"BCBS_FEP requires an appropriate ordering clinician (physician or qualified genetics professional); the test was ordered by/through an oncologist, which satisfies typical provider requirements.",No,"BCBS_FEP BRCA coverage requires a personal history of BRCA-related cancer or a family history of BRCA-associated cancers (e.g., breast, ovarian, pancreatic, or certain prostate cancers). This patient has no personal cancer history and the only reported family history is a maternal uncle with dystonia/ataxia (not BRCA-associated), so medical indication criteria are not met.",Not Specified,The provided clinical information notes a prior nondiagnostic karyotype but BCBS_FEP BRCA policy does not mandate prior cytogenetic testing as a prerequisite for BRCA1/2 sequencing; no payer-required prior tests for BRCA sequencing are specified here.,No,"BCBS_FEP BRCA eligibility depends on specific family history of BRCA-related cancers. The family history provided (an uncle with dystonia and ataxia) is not a BRCA-related cancer history, so the patient does not meet family-history criteria.",No,"BCBS_FEP typically requires documentation of pre-test genetic counseling for BRCA testing. The record states no pretest genetic counseling has been conducted, so counseling requirements are not met.",Not Specified,"None of the listed CPT options unambiguously corresponds to a standard full BRCA1/2 sequencing code (e.g., BRCA1/2 single-gene sequencing codes are not provided in the option list), so an exact CPT match cannot be determined from the supplied choices.",No,"Although age and ordering provider are acceptable, the patient lacks the payer-specified medical/family-history indications for BRCA1/2 testing and has no documented pre-test genetic counseling as required by BCBS_FEP; therefore the test is not covered under the payer's coverage criteria.",1960,2219,4179
Case2847,baseline,without_policy,iter3,WES,"The case statement explicitly says ""whole exome sequencing (WES) is being pursued to evaluate for an underlying genetic etiology.""",Yes,BCBS FEP genomic sequencing criteria allow WES for infants/children with suspected genetic disorders or critically ill neonates; the patient is a 5‑week‑old infant and therefore meets age‑related applicability for pediatric/infant WES.,Yes,"BCBS FEP generally permits the treating physician to order WES provided appropriate documentation and genetic counseling; this case documents a cardiology referral and completed pre‑test counseling with a genetic counselor, satisfying provider/counseling ordering requirements.",Yes,"Medical necessity criteria require a suspected underlying genetic etiology for significant, unexplained clinical presentations (e.g., life‑threatening events in infants). The infant had a high‑risk BRUE requiring CPR and is being evaluated for genetic causes, meeting clinical indication for WES.",Yes,"BCBS FEP sequencing policies commonly require prior basic testing such as chromosomal microarray when appropriate; the record states prior CMA testing was nondiagnostic, fulfilling required prior testing before WES.",Yes,"Family history can be relevant to genomic testing eligibility; here the mother has a persistent/severe immunologic or hematologic disorder, which is documented and relevant to consideration of a genetic etiology.",Yes,"BCBS FEP requires documentation of pre‑test genetic counseling for clinical genomic sequencing; the patient completed pre‑test counseling with a genetic counselor and has plans for post‑test follow‑up, meeting counseling requirements.",81415,CPT 81415 corresponds to clinical exome sequencing (WES) and best matches the requested test in this case.,Yes,"Based on BCBS FEP coverage criteria (infant with severe unexplained life‑threatening event, CMA nondiagnostic, documented genetic counseling, appropriate ordering), WES is medically necessary and covered for this patient.",1999,1399,3398
Case11855,baseline,without_policy,iter3,CMA,The patient information states chromosomal microarray (CMA) is being ordered to assess for copy number variants; CMA is explicitly requested.,Not Specified,UHC CMA coverage criteria are indication-based (developmental delay/ID/autism or congenital anomalies) and do not set a strict age cutoff; the patient is 14 but no age-based exclusion or requirement is specified.,Not Specified,"UHC coverage criteria for CMA focus on clinical indications rather than specifying a required ordering provider specialty; the record shows a developmental pediatrician ordered testing and a genetic specialist provided counseling, which is acceptable but no payer-mandated ordering-provider restriction is specified.",No,"UHC medical necessity criteria for CMA require unexplained developmental delay/intellectual disability, autism spectrum disorder, or multiple congenital anomalies. The patient has a congenital anomaly affecting a single organ system without documentation of developmental delay/ID/autism or multiple anomalies, so the specific coverage indications are not met.",Not Specified,"UHC CMA criteria do not require specific prior genetic tests as a universal prerequisite. Although Fragile X testing was performed (nondiagnostic), prior-test requirements for CMA are not defined in the policy.",Not Specified,"Family-history/consanguinity criteria are not part of standard CMA coverage requirements. The noted maternal aunt with triple-negative breast cancer is more relevant to hereditary breast cancer testing, not CMA; payer CMA criteria do not specify family-history requirements here.",Yes,"UHC expects documentation of informed genetic counseling when genetic testing is pursued. The patient completed pre-test counseling with a genetic specialist and plans for post-test follow-up were made, which satisfies counseling requirements.",81228,The requested test is chromosomal microarray; CPT code 81228 corresponds to chromosomal microarray analysis for copy-number variation.,No,"Applying UHC coverage criteria: although counseling is documented and age/provider are not exclusionary, the test is covered only for defined indications (unexplained developmental delay/ID/autism or multiple congenital anomalies). The patient has a single-organ congenital anomaly without documentation of developmental delay/ID/autism or multiple anomalies, so medical-necessity criteria are not met and CMA would not be covered.",2011,2345,4356
Case3465,baseline,without_policy,iter3,WGS,The patient information explicitly states whole genome sequencing (WGS) has been ordered.,Yes,UHC sequencing criteria apply to pediatric patients with unexplained developmental delay/intellectual disability; the patient is age 2 and therefore meets age-based (pediatric) eligibility.,Yes,"Payer criteria generally require ordering/oversight by a genetics professional for genome sequencing; the test was ordered while the patient is being evaluated by a medical geneticist and pre-test counseling was completed by a genetic counselor, meeting provider requirements.",Yes,UHC covers genomic sequencing for unexplained developmental delay/intellectual disability without a specific syndrome suspected; the patient has developmental delay/ID meeting that indication.,No,UHC typically requires prior first‑tier testing such as chromosomal microarray for unexplained developmental delay/ID; only Fragile X testing is reported (nondiagnostic) and CMA is not documented as completed.,Not Specified,"UHC sequencing criteria do not generally require a family history or consanguinity for coverage of WGS in DD/ID; while a paternal Long QT history is present, it is not specified as relevant to this WGS indication.",Yes,"UHC expects documented pre‑test genetic counseling for genomic sequencing; pre-test counseling was completed with a genetic counselor and plans exist for post‑test counseling, satisfying counseling requirements.",81425,"Among the provided CPT options, 81425 corresponds to whole genome sequencing (clinical genome sequencing) and best matches the ordered WGS.",No,"Although age, provider, indication, and counseling requirements are met, required prior testing (chromosomal microarray) is not documented; per UHC coverage rules WGS would not be approved until prior/CMA testing requirements are satisfied (or an exception documented).",1981,1939,3920
Case15557,baseline,without_policy,iter3,WGS,Patient information explicitly states whole genome sequencing (WGS) is being pursued.,Yes,UHC WES/WGS criteria generally apply to pediatric patients with unexplained congenital anomalies; the patient is 15 years old (pediatric) and therefore meets age-based eligibility.,Yes,"UHC policies require ordering by an appropriate treating specialist (e.g., geneticist or relevant specialist). The test was ordered via neurology (a relevant specialist), which meets ordering-provider requirements.",Yes,"UHC coverage criteria permit WGS for unexplained congenital anomalies/possible genetic etiology; the patient has a congenital anomaly since birth that remains unexplained, meeting medical indication criteria.",No,"UHC generally requires prior first‑tier testing such as chromosomal microarray (CMA) for congenital anomalies. Only FISH was performed and was nondiagnostic; CMA is not documented, so required prior testing is incomplete.",Yes,"UHC considers relevant family history in evaluation; the patient has a sibling with a similar congenital anomaly, which is relevant to eligibility and supports testing.",Yes,"UHC requires pre/post‑test genetic counseling for complex genomic testing. The patient has been seen multiple times by a genetic counselor with plans for post‑test counseling, meeting counseling requirements.",81425,The requested test is whole genome sequencing; CPT code 81425 corresponds to whole genome sequence analysis.,No,"Although age, clinical indication, ordering provider, family history, and counseling meet UHC criteria, required prior testing (notably chromosomal microarray as first‑tier testing for congenital anomalies) is not documented; failure to complete required prior testing means WGS is not covered under UHC policy in this case.",1978,1477,3455
Case4982,baseline,without_policy,iter3,WES,The clinical note explicitly states the patient is being considered for whole exome sequencing (WES) to evaluate for an underlying genetic etiology.,Not Specified,UHC WES coverage criteria are typically indication-based rather than strictly age-limited; the provided information (11-year-old) does not conflict with any specific age restriction in UHC WES policy.,Not Specified,The record does not state any payer-imposed specialty requirement for the ordering provider; UHC policies generally require an appropriate ordering clinician but do not rigidly specify a single specialty in most WES criteria.,Yes,"The patient has congenital Hirschsprung disease, is referred by a developmental pediatrician for genetic evaluation, and there is a sibling with early-onset (before age 3) epileptic encephalopathy — these features meet UHC medical-necessity indications for WES (suspected heritable syndromic/neurodevelopmental condition).",No,"UHC WES criteria commonly require prior appropriate testing (e.g., chromosomal microarray) for developmental anomalies; only nondiagnostic FISH was done and no CMA or other required prior testing is documented.",Yes,"The patient has a first-degree sibling with epileptic encephalopathy before age three, which is a relevant family history supporting evaluation for a heritable genetic syndrome per UHC criteria.",Yes,"UHC WES coverage typically requires documented pre-test genetic counseling; the family has met with a genetic counselor multiple times for pre-test counseling and plans post-test disclosure, meeting counseling requirements.",81415,"CPT 81415 corresponds to clinical whole exome sequencing (proband/exome sequencing interpretation and report), which best aligns with the requested WES.",No,"Although the clinical indications, family history, and genetic counseling meet UHC WES medical-necessity and counseling criteria, required prior testing (notably chromosomal microarray) is not documented; per UHC coverage rules, lack of required prior testing makes WES not covered at this time.",2007,1864,3871
Case14371,baseline,without_policy,iter3,WES,The clinical note explicitly states the general pediatrician ordered whole exome sequencing (WES).,Not Specified,UHC WES coverage is driven by clinical indications (unexplained developmental delay/ASD) rather than a strict age cutoff; no explicit age restriction is specified and the patient (11 years) is within the pediatric population typically considered.,Yes,"UHC requires an appropriate ordering clinician and documentation of genetic counseling; a general pediatrician may order testing when appropriate and the record documents pre-test genetic counseling, so ordering/provider requirements are met.",Yes,"UHC covers WES for unexplained complex neurodevelopmental disorders/autism spectrum disorder when used to evaluate a suspected genetic etiology; the patient has complex neurodevelopmental disorder and ASD, which meet the medical indication.",No,"UHC policy generally requires first‑tier testing (chromosomal microarray and Fragile X as indicated) prior to WES; Fragile X was nondiagnostic but no CMA is reported, so required prior testing is incomplete.",Not Specified,"While family history can inform interpretation, UHC WES eligibility is based on personal clinical phenotype and prior testing; the policy does not require specific family history/consanguinity for coverage and the provided family history is not a stated coverage criterion.",Yes,"UHC generally requires documentation of pre‑test genetic counseling for complex genomic testing; the family met with a genetic counselor before testing and planned post‑test follow up, satisfying counseling requirements.",81415,"CPT 81415 corresponds to clinical whole exome sequencing (proband), which matches the ordered WES.",No,"Although the patient meets clinical indication and counseling/provider requirements, UHC coverage requires completion of first‑tier testing (e.g., chromosomal microarray) prior to WES; CMA was not reported, so coverage would be denied until required prior testing is completed.",1983,1709,3692
Case15202,baseline,without_policy,iter3,BRCA1/2,The clinical note explicitly states she was referred for BRCA1 and BRCA2 testing to evaluate hereditary breast/ovarian cancer risk.,Not Specified,"BCBS_FEP BRCA criteria do not impose a strict age cutoff for testing; eligibility is based on personal/family cancer history rather than patient age alone, so no age-based exclusion/inclusion applies here.",Not Specified,"BCBS_FEP typically allows orders from treating physicians or genetics providers; the record shows referral by a gynecologist and pre-test counseling by a genetic specialist, and the policy does not state a restrictive ordering-provider specialty requirement.",No,"BCBS_FEP coverage for BRCA testing is tied to a personal or family history consistent with hereditary breast/ovarian cancer (e.g., epithelial breast carcinoma diagnosed at young age, ovarian cancer, multiple primaries, known family mutation). The patient’s breast diagnosis is a malignant phyllodes tumor (a stromal neoplasm, not a typical BRCA-associated epithelial breast cancer) and her family history does not report breast/ovarian cancer, so she does not meet the defined medical indications.",Not Specified,BCBS_FEP BRCA coverage criteria do not mandate completion of specific prior laboratory tests before BRCA germline testing; no required prior tests are documented in the patient record relevant to coverage criteria.,No,"BCBS_FEP family-history criteria require relatives with breast, ovarian, pancreatic, or related BRCA-associated cancers. The only reported family history is a sister with an immunologic/hematologic disorder, which is not a BRCA-related cancer history.",Yes,"BCBS_FEP and standard practice require pre-test genetic counseling for hereditary cancer testing; the record documents pre-test counseling with a genetic specialist and plans for post-test follow-up, satisfying counseling requirements.",Not Specified,The submission requests BRCA1/2 testing but the provided CPT options do not unambiguously map to the gene-specific BRCA1/2 procedure codes in this context; the record does not list a CPT and the available choices cannot be conclusively matched to BRCA1/2 based on the information given.,No,"Applying BCBS_FEP coverage criteria for hereditary breast/ovarian cancer testing, the patient lacks qualifying personal or family history (her breast tumor is a malignant phyllodes tumor, not a BRCA-associated epithelial breast cancer, and no family history of breast/ovarian cancer is reported). Although counseling requirements are met, the absence of a covered medical indication means the test is not covered.",1990,2357,4347
Case8621,baseline,without_policy,iter3,WES,The patient information explicitly states whole exome sequencing (WES) is being ordered.,Not Specified,"UHC coverage criteria for WES do not impose a strict age cutoff; pediatric patients with unexplained neurodevelopmental disorders are commonly eligible, so no specific age-based exclusion is specified.",Not Specified,"UHC policies for WES generally require an ordering clinician (licensed physician or qualified provider) but do not universally restrict ordering to a specific specialty; the record shows an MD (oncologist) ordered testing, and payer rules do not explicitly require a genetics specialist.",Yes,"UHC covers WES for unexplained complex neurodevelopmental disorders/autism spectrum disorder with additional features or when seeking a unifying diagnosis; this 2-year-old has complex neurodevelopmental disorder with autism, meeting medical indication criteria.",Yes,"UHC typically requires prior chromosomal microarray (CMA) testing before WES for developmental disorders; the record states prior CMA was completed and nondiagnostic, satisfying the prior test requirement.",Yes,"Family history/consanguinity can support testing eligibility. The family reports an uncle with a congenital anomaly, which is relevant family history per payer criteria.",Yes,"UHC often requires pre-test genetic counseling for WES; the family has met with a genetic counselor multiple times with pre-test counseling completed and plans for post-test follow-up, meeting counseling requirements.",81415,"The test requested is whole exome sequencing (proband), which corresponds to CPT code 81415 (exome sequencing, interpretation and report for an individual).",Yes,"Under UHC WES coverage criteria the patient meets key requirements: appropriate medical indication (complex neurodevelopmental disorder/autism), prior CMA nondiagnostic, relevant family history, and documented pre-test genetic counseling. Therefore the test is covered.",1988,1567,3555
Case14141,baseline,without_policy,iter3,WES,The clinical note explicitly states whole exome sequencing (WES) is planned to investigate an underlying genetic etiology.,Not Specified,"FEP WES coverage criteria do not impose an absolute age cutoff; eligibility is based on clinical presentation (e.g., multiple congenital anomalies/developmental disorder) rather than age, so no age-based exclusion applies.",Not Specified,"The patient data show referral by an oncologist but do not state the specific ordering provider credentials; FEP policies generally require an appropriate ordering clinician but do not always restrict to a single specialty in the policy language provided here, so ordering-provider specifics are not determinable from the supplied information.",Yes,"Under FEP WES coverage, testing is medically indicated for unexplained multiple congenital anomalies and neurodevelopmental disorders. The patient has multiple congenital anomalies and a neurodevelopmental context (sibling with global developmental delay), meeting those clinical criteria.",Yes,"FEP policies typically require prior chromosomal microarray (CMA) for unexplained developmental delay/MCAs; the record states CMA was performed and was nondiagnostic, satisfying the prior-test requirement.",Yes,The patient has a relevant family history (sibling with global developmental delay). FEP criteria consider family history/affected relatives relevant for genetic evaluation and may support WES (including consideration of trio testing).,Yes,"FEP WES coverage expects genetic counseling; the record documents pre-test genetic counseling completed and arrangements for post-test counseling, meeting counseling requirements.",81415,CPT 81415 corresponds to clinical exome sequencing (WES) with interpretation and report and is the appropriate code for the requested WES.,Yes,"Per FEP coverage rules, WES is covered for patients with unexplained multiple congenital anomalies/developmental disorders after nondiagnostic CMA; prior CMA was nondiagnostic, counseling is documented, and family history supports testing, so the request meets coverage criteria.",1983,1587,3570
Case6747,baseline,without_policy,iter3,WGS,The patient info explicitly states whole genome sequencing (WGS) was ordered by the medical geneticist to evaluate a suspected genetic etiology.,Yes,"BCBS_FEP WES/WGS criteria specify pediatric eligibility for unexplained congenital anomalies/developmental concerns; the patient is 12 years old, which meets pediatric age-related eligibility.",Yes,"BCBS_FEP requires ordering by a qualified clinician (typically a medical geneticist or clinician with genetics expertise) for WES/WGS; the test was ordered by a medical geneticist, meeting this requirement.",Yes,"Medical necessity criteria include multiple congenital anomalies and suspected genetic etiology after prior testing; the patient has multiple congenital anomalies and a suspected genetic disorder, satisfying indication criteria.",Yes,"BCBS_FEP typically requires prior chromosomal microarray (CMA) before WES/WGS unless contraindicated; the record states CMA was previously performed and nondiagnostic, meeting the prior-test requirement.",Yes,"Family history criteria (affected first-degree relative with developmental delay/related phenotype) are relevant for WES/WGS; the family reports a sibling with developmental delay, which is relevant to eligibility.",Yes,"BCBS_FEP requires documentation of genetic counseling for WES/WGS; pre-test counseling was completed and post-test counseling is planned, meeting counseling requirements.",81425,"Of the provided CPT options, 81425 is the code used in practice for large-scale genomic sequencing (WES/WGS) interpretation and reporting and best corresponds to the requested WGS.",Yes,"Applying BCBS_FEP coverage rules: patient meets age, specialist ordering, medical indication (multiple congenital anomalies, suspected genetic etiology), prior CMA nondiagnostic, family history, and counseling—therefore WGS is covered.",1966,1874,3840
Case811,baseline,without_policy,iter3,WES,The note explicitly states whole exome sequencing (WES) is being pursued to evaluate an underlying genetic etiology.,Yes,"BCBS_FEP WES criteria specify pediatric patients with early-onset unexplained neurodevelopmental / congenital anomaly presentations are eligible; the patient is a 7‑week‑old infant with early-onset movement disorder, meeting pediatric age-related indication.",Not Specified,BCBS_FEP policy requires an appropriate licensed ordering clinician and documentation of pre‑test counseling but does not strictly limit ordering to a specific specialty; here testing was referred by the general pediatrician and pre‑test counseling was completed by a genetic counselor.,Yes,"BCBS_FEP lists unexplained early-onset neurodevelopmental or multiple congenital anomaly presentations (including movement disorders/dystonia) as medical indications for WES; this infant has dystonia/ataxia/hemiplegic episodes and a sibling with congenital anomalies, meeting those clinical criteria.",Yes,"BCBS_FEP requires prior appropriate testing such as chromosomal microarray for congenital anomaly/developmental presentations; CMA was previously performed and reported nondiagnostic, satisfying the prior test requirement.",Yes,Family history/affected sibling is an accepted supporting criterion in BCBS_FEP WES coverage; the patient has a positive family history (older sibling with multiple congenital anomalies).,Yes,"BCBS_FEP requires documentation of genetic counseling for WES; pre‑test counseling was completed with a genetic counselor and post‑test follow‑up is planned, meeting counseling requirements.",81415,"CPT 81415 corresponds to exome sequencing (WES) with interpretation and report, which matches the requested test.",Yes,"Under BCBS_FEP WES policy, the patient meets coverage requirements: appropriate pediatric age/clinical indication (early severe movement disorder and possible syndromic features), prior CMA nondiagnostic, documented genetic counseling, and relevant family history; therefore WES is covered.",2018,1722,3740
Case7604,baseline,without_policy,iter3,WGS,The clinical note explicitly states 'whole genome sequencing (WGS) has been ordered' for the neonate.,Not Specified,"UHC WGS/WES policy is applied by clinical indication rather than a strict patient-age cutoff in typical published criteria; no explicit age exclusion or specific neonatal-only age requirement is stated in the provided policy context, so age-based criteria are not specified for this request.",Not Specified,"UHC policies generally do not mandate a single named ordering specialty in all cases (orders may come from treating physicians/geneticists), and the provided patient data only lists a referring neurologist — the policy does not explicitly require a specific ordering provider type in this scenario.",Yes,"UHC criteria support WGS/WES when there is suspected genetic etiology for multiple congenital anomalies and prior targeted testing was nondiagnostic. The neonate has multiple congenital anomalies across organ systems and nondiagnostic FISH, which meets a defined clinical indication for broader genomic testing.",No,"UHC commonly requires prior first‑line testing such as chromosomal microarray (CMA) for multiple congenital anomalies prior to WES/WGS unless emergent/critically ill NICU indication applies. The record documents FISH (nondiagnostic) but does not document prior CMA, so required prior testing has not been completed.",Yes,UHC coverage criteria consider positive family history of similar findings as relevant support. An older sibling with multiple congenital anomalies is documented and is relevant to eligibility.,No,"UHC typically requires documentation of pre-test genetic counseling (or counseling by qualified provider) for complex genomic testing. The family explicitly declined genetic counseling, so counseling requirements are not met.",81425,CPT 81425 corresponds to whole genome sequencing (WGS) with analysis and interpretation and is the appropriate code for the ordered test.,No,"Although the neonate meets clinical indication (multiple congenital anomalies, nondiagnostic targeted testing, positive family history), coverage prerequisites are not met per UHC criteria: chromosomal microarray (or other required prior testing) is not documented and required pre‑test genetic counseling was declined. Based on payer criteria, these unmet prerequisites lead to noncoverage.",1973,1638,3611
Case950,baseline,without_policy,iter3,WES,The note explicitly states whole exome sequencing (WES) is being pursued to look for an underlying genetic cause of early-onset epileptic encephalopathy.,Not Specified,UHC WES policies do not impose a strict age cutoff for diagnostic WES; the patient is 38 but had seizure onset <3 years. Age-based eligibility is not a limiting criterion in this clinical context.,Yes,"Payer criteria typically require an appropriate ordering specialist (geneticist/neurologist) or documentation that the provider is qualified; the test is being ordered by a medical geneticist, which satisfies provider requirements.",Yes,"UHC considers WES medically indicated for unexplained severe neurodevelopmental disorders/early-onset epileptic encephalopathy. The patient has unexplained epileptic encephalopathy with onset before age 3 and nondiagnostic cytogenetic testing, meeting medical indication criteria.",No,"UHC policies commonly require prior appropriate targeted testing (e.g., chromosomal microarray and/or epilepsy multigene panel) before WES unless documented rationale is given. The record shows only a nondiagnostic karyotype and explicitly notes no prior epilepsy multigene panel and no mention of CMA — required prior testing has not been completed.",No,"Although there is a family history of an uncle with prostate cancer, this family history is unrelated to eligibility for WES in early-onset epileptic encephalopathy; consanguinity or relevant family history criteria are not present.",Yes,"UHC requires documentation of genetic counseling for diagnostic WES. The patient has seen a genetic counselor multiple times and has plans for post-test counseling, satisfying counseling requirements.",81415,The CPT code that corresponds to clinical whole exome sequencing (proband/exome sequence analysis) is 81415.,No,"Although the medical indication, ordering provider, and counseling requirements are met, UHC generally requires completion of prior targeted testing (e.g., chromosomal microarray and/or epilepsy multigene panel) before WES. Required prior testing has not been completed per the record, so coverage would be denied until prior testing or a documented exception is provided.",2012,2211,4223
Case17822,baseline,without_policy,iter3,WGS,The patient information explicitly states whole genome sequencing (WGS) has been ordered as the next‑tier diagnostic test.,Not Specified,UHC genomic testing policies do not impose a strict age cutoff for WGS/WES; the record shows a 13‑year‑old but no age‑based exclusion or special age criterion is specified.,Yes,"UHC policies for WGS/WES require ordering by an appropriate genetics provider or specialist; the order was placed by a medical geneticist, which meets that provider requirement.",Yes,"UHC coverage criteria support WGS for patients with multiple congenital anomalies/multisystem involvement and suspected genetic etiology; the patient has multiple congenital anomalies affecting different organ systems, meeting the medical indication.",Yes,"UHC typically requires prior tiered testing (e.g., nondiagnostic chromosomal microarray) before WGS; the record states a nondiagnostic CMA was performed prior to ordering WGS.",Not Specified,"While a family history of a sibling with short stature is documented, UHC WGS eligibility does not generally require specific family history or consanguinity criteria, so family history is not a specified eligibility requirement here.",No,"UHC policy requires documentation of pre‑test genetic counseling for comprehensive genomic testing; the patient declined genetic counseling prior to testing, so the counseling requirement was not met.",81425,"CPT 81425 corresponds to whole genome sequencing (germline, comprehensive), which best matches the ordered WGS.",No,"Although age, provider, clinical indication, and prior nondiagnostic CMA meet UHC criteria, pre‑test genetic counseling is a coverage requirement and was declined (no documentation of completed counseling), so coverage would not be approved under UHC policy.",1985,1999,3984
Case9408,baseline,without_policy,iter3,WES,The patient information explicitly states the patient is undergoing whole exome sequencing (WES).,Yes,"FEP WES coverage is driven by early-onset clinical presentation (epileptic encephalopathy with seizure onset <3 years) rather than a strict maximum age; the patient is 17 and had onset before age 3, meeting the age-related/early-onset criterion.",Yes,"FEP policies require an appropriate ordering clinician (typically a medical geneticist, neurologist or other qualified physician); the test was requested by a medical geneticist, which satisfies provider requirements.",Yes,"FEP covers WES for unexplained epileptic encephalopathy/early-onset epilepsy when prior testing is nondiagnostic; the patient has epileptic encephalopathy with onset before age 3, a listed medical indication.",Yes,"FEP generally requires prior standard testing such as chromosomal microarray before WES for this indication; the record states CMA was previously performed and nondiagnostic, meeting prior test requirements.",No,"Although a family history is reported (mother with a severe immunologic/hematologic disorder), it is not described as a family history of epileptic encephalopathy or consanguinity relevant to WES eligibility per FEP criteria, so relevant family-history criteria are not met.",Yes,FEP requires documentation of pre-test genetic counseling and plans for post-test counseling for WES; the record documents pre-test counseling and planned post-test follow-up with a genetic counselor.,81415,CPT 81415 corresponds to exome sequencing (WES) for a proband; this best matches the requested WES.,Yes,"Per FEP WES coverage criteria the patient meets indication (early‑onset epileptic encephalopathy), required prior testing (nondiagnostic CMA), ordering provider (medical geneticist), and counseling requirements, so the test is covered.",1998,1774,3772
Case3592,baseline,without_policy,iter3,CMA,"The clinical note explicitly states ""chromosomal microarray (CMA) testing for developmental disorders is being requested.""",Not Specified,Cigna's CMA coverage is based on clinical indication (unexplained developmental delay/ID/ASD or congenital anomalies) rather than strict age cutoffs; no age-based exclusion for a neonate is specified.,Not Specified,Cigna medical policy for CMA does not generally mandate a specific ordering provider specialty; no provider-type requirement is provided in the case information.,Yes,The patient has neonatal-onset epileptic encephalopathy and unexplained developmental disorder—conditions that fall under Cigna's medically necessary indications for CMA (unexplained developmental delay/neurologic/developmental disorders).,Not Specified,"Cigna's CMA policy does not require specific prior testing before performing CMA (CMA is often first‑tier for developmental disorders); the record notes a prior CMA was nondiagnostic, but no required prior tests are defined.",Yes,"A relevant family history is documented (an older sibling with unexplained developmental regression), which is pertinent to genetic testing considerations per payer criteria.",Yes,"Cigna policies generally require or expect appropriate genetic counseling for genetic testing; pre-test counseling with a genetics specialist was documented and post-test follow-up is planned, meeting counseling expectations.",81228,CPT 81228 corresponds to chromosomal microarray/constitutional genome‑wide microarray testing (the appropriate code for CMA).,No,"Although the patient meets clinical indications for CMA, a prior CMA for this patient was nondiagnostic. Cigna typically does not cover repeat CMA on the same individual absent new clinical features, a different testing technology with clear justification, or other specified reasons. Given the prior nondiagnostic CMA and no documented justification for repeat CMA (e.g., new anomalies or use of a different validated platform), coverage is not supported.",1990,2413,4403
Case17929,baseline,without_policy,iter3,CMA,The referral states 'tumor chromosomal microarray (CMA) testing has been requested' explicitly.,Not Specified,UHC CMA coverage policies are not age-restrictive for pediatric patients with congenital anomalies or neurodevelopmental disorders; the policy applies across ages and does not impose a specific age cutoff.,Not Specified,UHC CMA policies do not mandate a specific ordering provider specialty (neurology referral is acceptable); no specialty restriction is specified in the coverage criteria.,Yes,"The patient is a child with a major abnormality affecting at least one organ system (congenital/major anomaly). UHC covers CMA for unexplained congenital anomalies/major structural abnormalities, so the medical indication is met.",Yes,"UHC policy for CMA in the setting of major congenital anomalies often requires prior karyotype to be nondiagnostic; the case states prior karyotype testing was nondiagnostic, satisfying that prerequisite.",Not Specified,Family-history criteria are not a determinant for CMA eligibility in UHC policy; the reported maternal BRCA1/2 pathogenic variants are unrelated to CMA coverage rules.,Not Specified,"UHC CMA coverage does not generally require documented genetic counseling as a formal eligibility criterion; although counseling was performed, counseling is not a specified coverage requirement.",Not Specified,"None of the listed CPT codes explicitly correspond to chromosomal microarray in standard coding; a CMA-specific code is not provided among the options, so the best choice is 'Not Specified.'",Yes,"Based on UHC coverage criteria: pediatric patient with a major congenital/structural abnormality, prior nondiagnostic karyotype, and neurologist/genetics involvement — CMA meets medical necessity and is covered.",1994,1929,3923
Case12834,baseline,without_policy,iter3,CMA,"The clinical note states 'chromosomal microarray (CMA) testing has been ordered' (requisition error noted as tumor-type vs germline), so CMA is the explicitly requested test.",Yes,Cigna's CMA coverage is driven by clinical presentation rather than a strict upper age cutoff for pediatric-onset neurodevelopmental disorders; the patient is 16 years old and therefore meets the age-related context for pediatric/ adolescent evaluation.,Not Specified,"Cigna CMA medical policy does not mandate a specific ordering provider specialty (e.g., only geneticist) for coverage in standard cases; the referral is from a developmental pediatrician which is an appropriate ordering provider, but the policy does not impose a unique provider-type requirement.",Yes,"Cigna considers CMA medically necessary for unexplained developmental delay/intellectual disability, autism spectrum disorder, or complex neurodevelopmental disorder affecting ≥1 organ system—this patient has a complex neurodevelopmental disorder meeting that criterion.",Not Specified,"Cigna policy does not generally require a specific prior test as an absolute precondition to CMA (CMA is often first-line); the record does note prior Fragile X testing was nondiagnostic, but the policy does not mandate Fragile X completion as a prerequisite.",Not Specified,"While a positive family history (consanguinity or affected relatives) can be relevant clinically, Cigna's CMA coverage criteria do not require specific family history to qualify; the patient does have a maternal uncle with dystonia/ataxia, but family-history criteria are not specified as a gating requirement.",Not Specified,"Cigna recommends genetic counseling for genomic testing, but the CMA policy does not list documented pre-test genetic counseling as a strict coverage requirement; the record indicates counseling is not documented.",81228,"CMA (chromosomal microarray analysis) is reported with the chromosomal microarray CPT code; among the provided options, 81228 corresponds to chromosomal microarray testing.",Yes,Patient meets Cigna's medical necessity criteria for CMA (16-year-old with complex neurodevelopmental disorder affecting ≥1 organ system; prior Fragile X nondiagnostic). Coverage is expected provided the specimen/test is correctly submitted as a germline constitutional CMA (the requisition should be corrected from tumor-type to germline for appropriate coverage/billing).,1991,2305,4296
Case4604,baseline,without_policy,iter3,WES,The case explicitly states whole exome sequencing (WES) is being requested to evaluate the child's developmental delay/intellectual disability.,Not Specified,BCBS_FEP WES coverage is driven by clinical indication (unexplained DD/ID) rather than an explicit age cutoff; the patient is pediatric (6 years) which is appropriate but the policy does not specify a strict age limit.,Not Specified,"BCBS_FEP policies typically require an ordering clinician and documentation of pre-test counseling but do not rigidly limit ordering to a single specialty in all cases; the provided information documents a PCP referral and genetic counselor involvement but does not state the specific ordering provider, so provider-specific requirement compliance cannot be confirmed or denied.",Yes,"The patient has unexplained developmental delay/intellectual disability without a specific syndromic diagnosis and a nondiagnostic CMA, which matches BCBS_FEP medical indications for WES in pediatric DD/ID.",Not Answerable,"A nondiagnostic CMA is documented (a common required prior test). BCBS_FEP may also recommend targeted testing (e.g., Fragile X where indicated) prior to WES; the record does not state whether any other required targeted tests were completed, so sufficiency of prior testing cannot be determined from the provided information.",Yes,The family reports an older sibling with moderate–severe intellectual disability diagnosed by age 18; BCBS_FEP considers family history of similar neurodevelopmental disorders relevant to WES eligibility.,Yes,"Pre-test counseling was completed with a genetic counselor and post-test follow-up is planned, meeting BCBS_FEP counseling requirements for WES.",81415,"CPT code 81415 corresponds to clinical exome sequencing (WES) for the proband, which is the test requested.",Yes,"Based on BCBS_FEP criteria: pediatric unexplained DD/ID, nondiagnostic CMA, relevant family history, and documented pre-test genetic counseling support medical necessity for WES; thus the test is covered pending any remaining required targeted testing (not documented) or standard administrative checks.",1995,2195,4190
Case8661,baseline,without_policy,iter3,WGS,The clinical note explicitly states whole genome sequencing (WGS) is requested to investigate a possible genetic cause.,Yes,UHC sequencing coverage distinguishes pediatric indications; the patient is 7 years old (pediatric) and therefore meets age-related eligibility for WGS in a child with suspected genetic disorder.,Yes,"UHC policies typically require ordering by a qualified specialist (e.g., geneticist or treating specialist). The test was ordered/referral placed by the child's neurologist, an appropriate specialist for neurologic/genetic evaluation.",Yes,"UHC coverage criteria support WGS for pediatric patients with unexplained major sensory impairment identified in childhood and/or family history of severe early-onset neurologic disease. This child has significant childhood-onset hearing/visual impairment and a sibling with early epileptic encephalopathy, meeting medical indication criteria.",No,"UHC typically requires prior targeted testing (e.g., chromosomal microarray as first-tier for congenital anomalies/developmental concerns) and other appropriate targeted tests; only Fragile X testing was performed (nondiagnostic) and no CMA or other prior genomic testing is documented.",Yes,Family history of a sibling with epileptic encephalopathy before age 3 is documented and is relevant to eligibility criteria that consider family history of early-onset severe neurologic disorders.,No,"UHC policies require documented pre-test genetic counseling by a qualified provider. Although counseling was offered, the family declined pre-test counseling and documentation of completed pre-test counseling is not present, so the counseling requirement is not met.",81425,"CPT code 81425 corresponds to whole genome sequencing (germline) interpretation/reporting, matching the requested WGS.",No,"Although age, ordering provider, clinical indication, and relevant family history support WGS, required prerequisites per UHC (documentation of prior appropriate testing such as CMA and completion of pre-test genetic counseling) are not met; therefore coverage would be denied pending those requirements.",2001,1915,3916
Case6451,baseline,without_policy,iter3,WGS,The patient information explicitly states 'whole genome sequencing (WGS) is being pursued.',Not Specified,UnitedHealthcare WGS/WES policy bases eligibility on clinical indication rather than a strict age cutoff; no age-based exclusion or specific minimum/maximum age is stated for WGS in the clinical context provided.,Not Specified,"UHC molecular testing policies generally require an ordering clinician but do not mandate a single specialty for WGS in all circumstances; the record shows a developmental pediatrician is ordering the test, and the payer policy does not explicitly restrict ordering to a geneticist.",Yes,"UHC covers WGS/WES for individuals with unexplained, significant neurodevelopmental findings (e.g., early infant hypotonia/possible genetic etiology, multiple congenital anomalies, or global developmental delay). The 7-week-old has significant hypotonia and evaluation by a developmental pediatrician, meeting clinical indication criteria.",No,UHC typically requires prior standard testing (such as chromosomal microarray) to be nondiagnostic before WGS/WES for developmental indications. The record states a prior karyotype was nondiagnostic but does not document a CMA; therefore required prior testing (CMA) has not been completed.,Not Specified,"Payer criteria may consider family history when relevant, but UHC WGS/WES coverage is driven primarily by the proband's clinical presentation; the maternal history of an immunologic/hematologic disorder is noted but does not correspond to a specified family-history requirement in the policy.",Yes,"UHC requires pre-test genetic counseling/documentation for high-complexity genomic testing; the record documents pre-test counseling was completed and post-test genetics follow-up is planned, satisfying counseling requirements.",81425,"CPT code 81425 corresponds to whole genome sequencing with analysis and interpretation, which matches the requested WGS test.",No,"Although the clinical indication (infant with significant hypotonia) meets UHC medical necessity criteria for WGS, UHC policy requires completion of specified prior testing (typically chromosomal microarray) before WGS in non-critically ill infants. A CMA is not documented (only a nondiagnostic karyotype), so coverage criteria are not fully met.",1975,1775,3750
Case19255,baseline,without_policy,iter3,BRCA1/2,Patient was referred specifically for BRCA1/2 testing to evaluate hereditary breast/ovarian cancer predisposition.,Yes,"UHC-style hereditary cancer criteria specify age-based indications (e.g., breast cancer diagnosed <50 or multiple primary breast cancers). The patient is 38 and has two separate primary breast cancers, meeting age-related/diagnosis-based criteria.",Yes,"UHC generally requires ordering by an authorized physician or qualified provider; the order originates from a neurologist (physician) and pre-test counseling occurred with a genetics specialist, satisfying provider requirements.",Yes,"Medical necessity criteria for BRCA testing include individuals with multiple primary breast cancers and/or early-onset breast cancer. The patient has two separate primary breast cancers and is age 38, meeting those clinical indications.",Not Specified,UHC hereditary BRCA criteria do not typically mandate completion of specific prior genetic tests before BRCA1/2 testing in a proband with qualifying personal history; the provided prior FISH result is unrelated and nondiagnostic.,Yes,"Family-history criteria are part of BRCA coverage rules; the patient reports a first‑degree relative (father) with metastatic prostate cancer, which is relevant to BRCA-associated cancer spectrum and supports testing.",Yes,"UHC commonly requires documentation of genetic counseling for hereditary cancer testing. The record states pre-test counseling was completed with a genetic specialist, meeting counseling requirements.",Not Specified,"Typical CPTs for single‑gene BRCA1/BRCA2 sequencing (e.g., 81211/81213) are not among the provided options; therefore a best-match CPT cannot be selected from the given list.",Yes,"Based on UHC-style coverage criteria: the patient meets clinical indications (two primary breast cancers and age <50), has relevant family history, pre-test counseling is documented, and an appropriate ordering provider is involved — therefore BRCA1/2 testing is covered.",1972,2613,4585
Case2211,baseline,without_policy,iter3,BRCA1/2,The referral specifically requests BRCA1 and BRCA2 testing for hereditary breast/ovarian cancer risk; patient and family history and a known BRCA2 pathogenic variant in the mother are described.,Not Specified,UHC BRCA/familial-variant policies do not impose a strict age cutoff for predictive testing when a known familial pathogenic variant exists; the record shows the patient is 21 but policy does not specify an age restriction for this scenario.,Not Specified,UHC generally requires an appropriate ordering clinician but does not usually restrict BRCA orders to a single specialty in its coverage criteria; the case notes the order was placed after genetics specialist counseling but the policy does not state a restrictive provider-type requirement.,Yes,"Medical necessity criteria are met: patient has a personal history of a primary solid tumor plus a strong family history and a first-degree relative (mother) with a known BRCA2 pathogenic variant, which satisfies UHC indications for BRCA testing (diagnostic or predictive).",Yes,"When a known familial pathogenic BRCA variant exists, prior testing of an affected relative (here, the mother with a known BRCA2 pathogenic variant) satisfies the requirement to pursue targeted testing in the proband; no additional prior testing of the proband was required.",Yes,"Family history is clearly relevant: mother is reported to carry a BRCA2 pathogenic variant and there are ≥2 additional affected blood relatives on the same side, meeting family-history criteria in the payer policy.",Yes,"UHC criteria require appropriate pre-test genetic counseling for hereditary cancer testing; the record documents pre-test counseling by a genetic specialist and plans for post-test follow-up, meeting counseling requirements.",81162,"Because a known familial BRCA2 pathogenic variant is reported, the appropriate billing code is for targeted analysis of a known familial variant (CPT 81162) rather than full-sequence BRCA panel or exome/genome codes.",Yes,"Based on UHC coverage rules, the presence of a known BRCA2 pathogenic variant in a first-degree relative plus the patient's personal cancer history and completed pre-test genetic counseling meets medical necessity for targeted BRCA testing; therefore the test is covered.",2000,2028,4028
Case18882,baseline,without_policy,iter3,WES,The clinical note explicitly states 'whole exome sequencing (WES) is being requested.',Not Specified,"UHC WES coverage criteria are driven by clinical indication rather than a strict age cut‑off; no age‑based exclusion for an 8‑year‑old is specified, so age criteria are not specifically limiting here.",Not Specified,"UHC policies commonly require appropriate ordering clinician and documentation of counseling, but they do not universally mandate a single specific specialty for ordering WES. The referral is from a developmental pediatrician (an appropriate specialist), but payer policy does not strictly limit ordering to one named specialty in a way that can be confirmed from the provided data.",Yes,"UHC authorizes WES for patients with an unexplained, multisystem/congenital anomaly phenotype or complex neurodevelopmental disorders after standard testing. This 8‑year‑old has multiple congenital anomalies affecting several organ systems and thus meets medical indication criteria.",No,"UHC WES criteria typically require prior standard cytogenomic testing (e.g., chromosomal microarray) or other indicated targeted testing before WES. The record notes prior FISH was nondiagnostic but does not document a CMA or other required prior testing.",Yes,"Family history/affected first‑degree relative (mother with long QT syndrome) is present. While not necessary to approve WES, payer criteria list relevant family history as supportive; here a relevant genetic family history exists.",No,"UHC commonly requires documentation of pre‑test genetic counseling/informed consent for clinical WES. The family declined pre‑test counseling and the plan is to coordinate post‑test counseling, so counseling requirements are not met at the time of ordering.",81415,"CPT code 81415 corresponds to clinical exome sequencing (WES), which is the test requested.",No,"Although the patient meets clinical indication for WES, required prior testing (e.g., chromosomal microarray) and required pre‑test genetic counseling/documentation are not completed; per UHC coverage rules these unmet prerequisites make the request not covered as submitted.",1978,2073,4051
Case14408,baseline,without_policy,iter3,BRCA1/2,The patient was referred specifically for BRCA1/2 testing (statement: 'referred ... for BRCA1/2 testing').,Not Specified,"Cigna BRCA coverage criteria do not impose a hard age cutoff for testing; eligibility is based on personal/family history rather than patient age, and the record gives no age-based exclusion.",Not Specified,"Cigna policies typically do not restrict ordering to a specific specialty (primary care providers may order testing when appropriate), and no payer-specific ordering-provider restriction is documented in the patient information.",Yes,"Under Cigna (NCCN-based) BRCA coverage, an unaffected individual with a first-degree relative who had male breast cancer meets a qualifying family-history indication; patient has a brother with breast cancer (first-degree male breast cancer).",Not Answerable,"Cigna guidance prefers testing an affected family member first when available, but the record does not state whether the affected brother is available for testing or whether targeted family testing was offered; therefore it cannot be determined whether a required prior test was completed.",Yes,Family-history criteria are relevant and met: patient has a first-degree relative (brother) with breast cancer (male breast cancer is a BRCA-related family history trigger).,Yes,"Cigna requires documentation of pre-test genetic counseling for BRCA testing; the patient completed pre-test counseling and post-test follow-up is planned, satisfying counseling requirements.",81228,"The request is for diagnostic/full BRCA1/2 gene testing (full sequencing/analysis); among provided options, 81228 most closely corresponds to BRCA1/BRCA2 testing (full-gene analysis).",Yes,"Patient meets Cigna family-history medical indication for BRCA testing (first-degree relative with male breast cancer), pre-test counseling documented, and no disqualifying factors are present; therefore test is covered under applicable BRCA coverage criteria.",1957,2420,4377
Case4262,baseline,without_policy,iter3,WES,The clinical note explicitly states the infant was referred for diagnostic whole exome sequencing (WES).,Not Specified,BCBS FEP WES coverage criteria do not impose a strict age cutoff for diagnostic WES; age (5 weeks) is not a limiting factor in the payer's WES eligibility rules.,Yes,"BCBS FEP requires an appropriate ordering clinician (licensed physician) and documentation of genetics involvement; the test was ordered by the patient's oncologist (physician) and pre-/post-test genetics involvement is documented, meeting ordering/provider requirements.",Yes,"BCBS FEP medical necessity criteria for WES include individuals with multiple congenital anomalies or an unexplained suspected monogenic disorder after standard testing; the infant has multiple congenital anomalies not fitting a known syndrome and was referred for diagnostic WES, meeting indication.",No,"BCBS FEP generally requires prior recommended first‑tier testing (chromosomal microarray) or equivalent cytogenetic testing before WES for congenital anomalies; only a nondiagnostic karyotype is documented and no CMA is reported, so required prior testing has not been completed.",Yes,"Family history criteria for WES allow consideration when a first‑degree relative has potentially related events; a sibling had a brief resolved unexplained event with cyanosis/irregular breathing, which is relevant family history supportive of testing.",Yes,"BCBS FEP requires documentation of pre‑test genetic counseling for WES; the record states pre‑test genetic counseling was completed and post‑test genetics follow‑up is planned, satisfying counseling requirements.",81415,The requested test is diagnostic whole exome sequencing for a single proband; CPT 81415 corresponds to exome sequencing (proband only) per coding guidance.,No,"Although the patient meets clinical indications, has appropriate provider involvement, and counseling is documented, BCBS FEP requires completion of specified prior testing (chromosomal microarray) for congenital anomalies prior to WES; CMA is not documented, so coverage would not be approved per payer criteria.",1990,1674,3664
Case10363,baseline,without_policy,iter3,WGS,The clinical note explicitly states whole genome sequencing (WGS) is being pursued.,Not Specified,UHC WES/WGS coverage criteria do not impose a strict age cutoff for pediatric congenital anomaly evaluations; no age-based exclusion applies to this 7‑year‑old in the policy.,Yes,"UHC generally requires ordering by or in consultation with a genetics professional. The patient was referred by a GP but has had multiple pre‑test visits with a genetic counselor, satisfying the requirement for genetics involvement per UHC policy.",Yes,UHC coverage criteria support WGS for unexplained congenital anomalies / longstanding multisystem congenital findings after prior targeted testing is nondiagnostic; this patient has a congenital anomaly since birth and nondiagnostic targeted testing (FISH).,No,UHC typically requires prior chromosomal microarray (and/or other standard cytogenetic testing) before WES/WGS for congenital anomaly workup; only nondiagnostic FISH is documented and no CMA result is provided.,Not Specified,Family history for hereditary cancer panels is noted (maternal aunt with pancreatic cancer) but UHC WGS eligibility for congenital anomalies does not specify family history/consanguinity as a required criterion in this context.,Yes,"UHC requires pre‑ and post‑test genetic counseling for high‑complexity genomic testing; the patient has had multiple pre‑test genetic counseling visits and planned post‑test follow‑up, meeting counseling requirements.",81425,CPT code 81425 corresponds to whole genome sequencing (WGS) with analysis/interpretation and is the appropriate code for the requested test.,No,"Although indication, genetics involvement, and counseling are satisfied, UHC requires prior standard cytogenetic testing (e.g., chromosomal microarray) before WGS for congenital anomalies; CMA is not documented, so the coverage criteria are not fully met.",1999,1898,3897
Case9349,baseline,without_policy,iter3,WES,The patient is explicitly referred for whole exome sequencing (WES) in the provided clinical information.,Not Specified,BCBS_FEP WES coverage criteria do not impose a strict age cutoff for exome testing; the patient is a pediatric case (5 years) but no age-based exclusion/inclusion criterion is specified that would affect eligibility.,Not Specified,"BCBS_FEP policies generally require an appropriate ordering clinician but do not universally mandate a single specialty for ordering WES. Here the patient was referred by a cardiologist and had pre-test genetic counseling, which satisfies typical provider/counseling expectations; the policy does not specify that only a geneticist may order testing.",Yes,"BCBS_FEP criteria support WES when a patient has a congenital anomaly with suspected genetic etiology and a relevant family history suggesting an inherited disorder. The patient has a congenital cardiac anomaly and a paternal uncle with sudden unexplained death <35, meeting medical indication for WES per payer criteria.",Not Specified,"BCBS_FEP often expects prior targeted testing when appropriate, but for a single-organ congenital cardiac anomaly with strong family history of sudden death, the policy does not uniformly require a specific prior test such as CMA before WES. The record documents a nondiagnostic FISH; no explicit CMA requirement is stated in the provided policy context.",Yes,Family history criteria are relevant for WES per BCBS_FEP; the paternal uncle's sudden unexplained death before age 35 constitutes a concerning family history that supports testing.,Yes,"BCBS_FEP requires pre-test genetic counseling for complex genomic testing; the record documents that pre-test counseling was completed with a genetic counselor and plans for post-test follow-up are confirmed, meeting counseling requirements.",81415,CPT 81415 corresponds to whole exome sequencing (sequence analysis and interpretation) and best maps to the requested WES in this clinical scenario.,Yes,"Under BCBS_FEP criteria WES is covered when there is a suspected genetic etiology for a congenital anomaly, relevant family history suggesting inherited disease, and appropriate genetic counseling. The patient is a 5-year-old with a congenital cardiac anomaly, a paternal uncle with sudden unexplained death <35, nondiagnostic prior (FISH) testing, completed pre-test counseling, and planned follow-up—together meeting payer medical necessity and coverage requirements.",1990,1997,3987
Case1428,baseline,without_policy,iter3,WGS,The clinical note explicitly states 'whole genome sequencing (WGS) has been ordered.',Yes,"UHC WGS/WES coverage is specified for pediatric patients with congenital anomalies or early-onset neurodevelopmental concerns; the patient is a 3‑week‑old infant (pediatric), so age-based eligibility (pediatric) is met.",Yes,"UHC policies require ordering by an appropriate qualified provider (geneticist/genetics specialist) for complex genomic testing; the ordering provider is a medical geneticist, which meets the provider requirement.",Yes,UHC defines medical indications including unexplained congenital anomalies and suspicion of a genetic disorder (family history of severe intellectual disability); Hirschsprung disease in an infant plus an affected sibling constitutes a clinical indication for genomic evaluation.,No,"UHC generally requires prior first‑line testing (e.g., chromosomal microarray) to be performed and nondiagnostic before WES/WGS except in specific exceptions (e.g., critically ill NICU cases); only Fragile X testing was done and CMA is not documented, so required prior testing has not been completed.",Yes,"There is a relevant family history: an older sibling with severe intellectual disability diagnosed by age 18, which is pertinent to eligibility criteria that consider family history of neurodevelopmental disorders.",No,"UHC typically requires documentation of pre‑test genetic counseling by an appropriate professional for comprehensive genomic testing; the record states there is no documented pre‑test genetic counseling, so counseling requirements are not met.",81425,"Among the provided CPT options, 81425 corresponds to whole genome sequencing (WGS) analysis and reporting, matching the ordered test.",No,"Although age, ordering provider, clinical indication, and family history support WGS, UHC coverage requires prior first‑line testing (notably chromosomal microarray) and documentation of pre‑test genetic counseling except in narrow exceptions (e.g., critically ill neonates). Those prior testing and counseling requirements are not satisfied in the provided information, so the test would not meet UHC coverage criteria as documented.",1969,1941,3910
Case3359,baseline,without_policy,iter3,WES,The clinical note explicitly states Whole Exome Sequencing (WES) is being requested to evaluate an underlying genetic etiology.,Yes,"UHC WES criteria specify pediatric patients with unexplained developmental delay/intellectual disability as eligible; the patient is a 4-year-old child, which meets pediatric age-based eligibility.",Yes,"UHC requires ordering by an appropriate specialist or in consultation with genetics; the request is from a developmental pediatrician and pre-test counseling was performed by a genetic counselor, meeting provider requirements.",Yes,"UHC medical-necessity criteria include significant unexplained developmental delay/hypotonia and nondiagnostic CMA—this patient has significant hypotonia, ongoing developmental concerns, and prior nondiagnostic CMA, satisfying clinical indications.",Yes,"UHC generally requires prior CMA for developmental delay before WES; the record states chromosomal microarray was previously performed and nondiagnostic, satisfying prior test requirements.",Yes,"Family-history criteria (affected first-degree relative with developmental delay) are relevant to WES eligibility; the patient has a sibling with developmental delay, which is relevant.",Yes,"UHC requires documented pre-test genetic counseling for WES; the patient had multiple pre-test counseling sessions with a genetic counselor and post-test follow-up is planned, meeting counseling requirements.",81415,CPT 81415 corresponds to whole exome sequencing (proband or exome testing) and best matches the requested WES.,Yes,"All applicable UHC coverage criteria are met: appropriate pediatric age, qualifying clinical indications (developmental delay/hypotonia), prior nondiagnostic CMA completed, relevant family history, appropriate ordering provider and documented genetic counseling—therefore WES is covered.",1993,1669,3662
Case9978,baseline,without_policy,iter3,WES,The patient record explicitly states the patient is undergoing whole exome sequencing (WES) requested by the neurologist.,Yes,"UHC WES coverage typically requires early-onset neurologic/developmental presentation (often childhood); seizures/encephalopathy began before age 3, meeting the age/onset requirement.",Not Specified,"UHC policies emphasize appropriate clinical documentation and genetic counseling but do not universally mandate a single specific ordering provider specialty — the record shows a neurologist ordered testing, which is commonly acceptable, but the policy does not strictly specify provider type.",Yes,"Coverage criteria support WES for unexplained early-onset epileptic encephalopathy/neurodevelopmental disorder; the patient has persistent epileptic encephalopathy with onset <3 years, meeting medical indication.",No,"UHC typically requires prior appropriate testing (e.g., chromosomal microarray and Fragile X) before WES for neurodevelopmental disorders; Fragile X was done and nondiagnostic, but no documentation of prior chromosomal microarray is provided.",Yes,"Family-history criteria are relevant for WES and the patient has a brother with an inborn error of metabolism, which is a relevant family history supporting genetic testing.",Yes,"UHC requires documentation of pre-test genetic counseling for WES; the patient completed pre-test counseling with a genetic counselor and plans post-test follow-up, satisfying counseling requirements.",81415,CPT 81415 corresponds to clinical exome (WES) sequencing and best matches the requested test.,No,"Although age, clinical indication, family history, counseling, and appropriate CPT mapping are met, UHC generally requires prior chromosomal microarray (and other appropriate prior testing) before authorizing WES; no CMA is documented, so coverage criteria are not fully satisfied.",1973,1756,3729
Case22,baseline,without_policy,iter3,BRCA1/2,The patient is explicitly undergoing BRCA1/2 testing as stated in the clinical information.,Not Specified,BCBS FEP coverage criteria for germline BRCA testing do not impose a strict age cutoff for adults; the patient is 18 but no payer-specific age restriction for BRCA1/2 testing is specified in typical BCBS_FEP hereditary cancer policies.,Not Specified,"BCBS_FEP policies generally require an order from a qualified provider but do not mandate a specific specialty (e.g., must be oncology or genetics). The record shows a physician (neurologist) ordered testing; payer-specific ordering-specialty restrictions are not specified.",Yes,"BCBS_FEP and guideline-based coverage include germline BRCA testing for patients with metastatic high-risk prostate cancer. The patient has metastatic prostate cancer with intraductal/cribriform histology, meeting a covered medical indication.",Not Specified,"BCBS_FEP coverage for germline BRCA testing does not require prior genetic tests (e.g., CMA) to be completed; the provided prior CMA being nondiagnostic is noted but prior testing is not a precondition in the coverage criteria.",Yes,"Family-history criteria are relevant for hereditary cancer testing and are specified in BCBS_FEP policies; the patient’s father had metastatic high-risk prostate cancer with intraductal/cribriform features, which is a relevant family history supporting testing.",Yes,"BCBS_FEP typically requires documentation of pre-test genetic counseling for hereditary cancer testing. The patient completed pre-test counseling and plans post-test follow-up, satisfying counseling requirements.",81228,"The requested test is BRCA1/2 single-gene germline testing. Although the usual BRCA CPTs (e.g., 81211/81213) are not listed among choices, 81228 is the option from the 812xx single-gene/mutation analysis series provided that best corresponds to BRCA testing versus the offered panel/exome/genome codes.",Yes,"From a BCBS_FEP adjudication perspective the patient meets medical necessity (metastatic high-risk prostate cancer), has relevant family history, and has completed required pre-test counseling; therefore BRCA1/2 germline testing is covered.",2011,2554,4565
Case5605,baseline,without_policy,iter3,WGS,The patient was referred for whole genome sequencing (WGS) per the provided clinical information.,Not Specified,BCBS_FEP WGS/WES coverage criteria are based on clinical indications rather than strict age cutoffs; no payer-specific age exclusion is stated and an 11-year-old is within the pediatric/adult range typically considered.,Not Answerable,"Payer policy commonly requires ordering/authorization by or in consultation with a genetics specialist. The record notes pre-test counseling with a genetic specialist but does not explicitly state who placed the WGS order, so available information is insufficient to confirm ordering-provider requirements are met.",Yes,BCBS_FEP coverage criteria support WGS/WES for individuals with major congenital anomalies or unexplained multiple congenital malformations. The patient has a major congenital cardiac anomaly and thus meets a defined medical indication.,Yes,"Payer criteria commonly require prior chromosomal microarray (CMA) before WES/WGS; the patient had a nondiagnostic CMA, satisfying the prior-test requirement.",No,"While payer criteria may consider family history/consanguinity relevant (eg, similarly affected relatives), the only family history noted is a maternal aunt with pancreatic cancer, which is not a relevant family history for the patient’s congenital cardiac anomaly per typical eligibility rules.",Yes,"BCBS_FEP typically requires pre-test genetic counseling for WGS/WES. The record states pre-test counseling was completed with a genetic specialist, meeting counseling requirements.",81425,"Of the listed CPT options, 81425 corresponds to whole genome sequencing (WGS) analysis and interpretation; 81415 more commonly maps to whole exome sequencing.",Yes,"The patient meets clinical-necessity criteria for WGS (major congenital anomaly), has a nondiagnostic prior CMA, and completed pre-test genetic counseling — aligning with BCBS_FEP coverage requirements for WGS/WES, so the test is covered.",1969,2033,4002
Case19162,baseline,without_policy,iter3,WGS,The clinical note states the medical geneticist referred the neonate for whole genome sequencing (WGS).,Yes,BCBS_FEP coverage for WGS includes pediatric/neonatal patients with suspected genetic disorders; the patient is a neonate and therefore meets age-based eligibility.,Yes,"BCBS_FEP policies require WGS be ordered by an appropriate qualified clinician (e.g., medical geneticist); the ordering provider is a medical geneticist, meeting that requirement.",Yes,"BCBS_FEP medical necessity criteria include infants/neonates with complex neurologic abnormalities or suspected genetic/metabolic disorders; this neonate has dystonia, ataxia, asymmetric weakness and a sibling with an IEM, which meets those clinical indications.",Not Specified,"For critically ill neonates or infants with significant neurologic findings, BCBS_FEP allows WGS without mandatory prior testing (although targeted tests may be reasonable). The record documents prior Fragile X testing (nondiagnostic) but does not indicate a required prior CMA; the policy does not strictly mandate specific prior tests in this scenario.",Yes,"BCBS_FEP considers relevant family history (e.g., sibling with an inborn error of metabolism) supportive of WGS coverage for a suspected genetic disorder; this family history is present.",Yes,"BCBS_FEP requires pre-test genetic counseling for WGS; the record documents pre-test counseling with a genetic counselor and planned post-test follow-up, satisfying counseling requirements.",81425,"CPT 81425 corresponds to whole genome sequencing (WGS), which is the test requested.",Yes,"Under BCBS_FEP criteria the neonate meets age, ordering-provider, clinical indication, family-history and counseling requirements for WGS; prior testing does not preclude coverage in this critically affected neonate. Therefore WGS is covered.",1999,1827,3826
Case15834,baseline,without_policy,iter3,WES,The note explicitly states whole exome sequencing (WES) has been ordered to assess for an underlying genetic etiology.,Yes,"UHC WES pediatric criteria apply; patient is an infant (pediatric), so age-based eligibility for pediatric WES is met.",Yes,"UHC typically requires or prefers ordering/ counseling by a genetics provider for WES; pre-test counseling was completed with a genetic specialist and testing was referred by the PCP, meeting ordering/provider requirements.",No,"UHC coverage for WES generally requires unexplained developmental delay/intellectual disability, multiple congenital anomalies, or ASD with additional features (e.g., ID, congenital anomalies, seizures). The infant has early signs concerning for ASD only and no documented developmental delay, ID, seizures, or patient congenital anomalies.",No,UHC WES policies commonly require prior first-tier testing such as chromosomal microarray (CMA) (and Fragile X where indicated). Only Fragile X testing was completed (nondiagnostic); CMA is not documented.,Yes,A maternal aunt with a congenital anomaly is documented. Family history of a congenital anomaly is relevant under UHC criteria as supportive evidence of a possible genetic etiology.,Yes,"Genetic pre-test counseling was completed with a genetic specialist, which satisfies UHC counseling requirements for WES.",81415,The CPT code that corresponds to clinical exome sequencing (WES) is 81415.,No,"Although age, provider, counseling, and some family-history support are met, UHC coverage requires specific clinical indications (e.g., developmental delay/ID or ASD with additional features) and prior first-tier testing (CMA). The patient lacks documented qualifying clinical features and has no documented CMA, so WES is not covered.",1974,1429,3403
Case13,baseline,without_policy,iter3,WES,The case states the newborn 'has been referred for whole exome sequencing (WES)'; that is the explicitly requested test.,Not Specified,BCBS FEP coverage criteria for WES focus on clinical indications rather than strict age cutoffs; no age-based exclusion is specified for pediatric or neonatal WES in the provided clinical context.,Not Specified,BCBS FEP WES policies emphasize documentation of genetic counseling and appropriate clinical ordering but do not mandate a specific ordering provider specialty in this scenario; the record shows a general pediatrician referral and counseling was completed.,Yes,"BCBS FEP WES medical-necessity criteria include newborns with multiple congenital anomalies not fitting a defined syndrome and/or unexplained neurodevelopmental regression in family—both present (multiple congenital anomalies in the proband and an affected sibling), satisfying an indication for WES.",No,"BCBS FEP typically requires prior appropriate cytogenomic testing (chromosomal microarray) prior to WES for congenital anomalies/ID. The record states only a nondiagnostic karyotype was done; a CMA is not documented, so required prior testing is incomplete.",Yes,"Family history is relevant per BCBS FEP criteria; the patient has a sibling with unexplained developmental regression, which supports WES eligibility under familial/neurodevelopmental criteria.",Yes,"BCBS FEP requires documentation of pre-test genetic counseling for WES; the note states pre-test genetic counseling was completed and post-test follow-up is planned, meeting counseling requirements.",81415,The requested test is whole exome sequencing; the CPT code from the provided options that corresponds to WES is 81415.,No,"Although clinical indications and counseling are met, BCBS FEP requires prior cytogenomic testing (chromosomal microarray) before WES for multiple congenital anomalies/related indications; CMA is not documented (only a nondiagnostic karyotype), so coverage criteria are not fully met.",1976,1660,3636
Case16487,baseline,without_policy,iter3,WES,The clinical note explicitly states 'whole exome sequencing (WES) has been ordered.',Yes,"Patient is a newborn. UHC WES coverage policies permit WES for pediatric/neonatal patients with suspected genetic disorders or unexplained critical events (no upper/lower age exclusion), so the infant's age meets age-based eligibility.",Not Specified,UHC policies generally require appropriate clinical justification and documentation of counseling rather than narrowly restricting ordering to a single specialty. The record shows an oncologist ordered testing and counseling was completed; payer policy does not explicitly mandate a specific ordering specialty in this scenario.,Yes,UHC covers WES when there is a suspected underlying genetic etiology after nondiagnostic prior testing or when clinical presentation is consistent with a genetic disorder. Recurrent high‑risk BRUE with nondiagnostic FISH and concern for an underlying disorder meets a medical indication for WES per payer criteria.,Not Specified,"Payer policies often expect prior targeted testing where appropriate; here FISH was performed and nondiagnostic. UHC does not have a uniform requirement that CMA must precede WES for every presentation like BRUE, so specific prior‑test requirements are not clearly specified from the provided information.",Yes,Family history can support medical necessity for WES under UHC rules. The maternal aunt's persistent severe immunologic/hematologic disorder is relevant and strengthens the genetic testing indication.,Yes,"UHC requires documentation of pre‑test counseling and plans for post‑test follow‑up for complex genomic testing. The record states pre‑test counseling was completed and post‑test genetic follow‑up is planned, meeting counseling requirements.",81415,"CPT 81415 corresponds to clinical exome sequencing (proband), which matches the ordered whole exome sequencing.",Yes,"Under UHC criteria the neonate has a covered indication: recurrent high‑risk BRUE with nondiagnostic targeted testing, relevant family history, completed pre‑test counseling and plan for follow‑up. Age and documentation meet coverage requirements for WES.",1985,1870,3855
Case3677,baseline,without_policy,iter3,BRCA1/2,The patient is explicitly described as 'undergoing BRCA1/2 testing.',Not Answerable,"UHC BRCA criteria include age-based elements (e.g., age at breast cancer diagnosis thresholds). The record gives current age (46) but does not state age at breast cancer diagnosis, so there is insufficient information to determine whether she meets age-based criteria.",Not Specified,"UHC policies generally require appropriate ordering and documentation but do not universally restrict ordering to a specific specialty in the provided information. The record shows an NP referral, but the payer-specific requirement for ordering provider type is not explicitly provided here.",Yes,"Under UHC BRCA coverage criteria, testing is indicated for individuals with a personal history of breast cancer and/or a close relative with BRCA-associated cancers (including pancreatic). The patient has a personal history of breast cancer plus a close relative (mother) with pancreatic cancer and multiple affected maternal relatives, meeting medical indication.",Not Specified,There is no UHC requirement in the provided context that prior genetic tests must be completed before BRCA1/2 testing; the noted prior CMA was nondiagnostic but not a prerequisite for BRCA testing.,Yes,Family history criteria are relevant for BRCA testing and are met: mother with pancreatic cancer and at least two additional affected maternal relatives (multiple BRCA-related cancers on same side of family).,Yes,"UHC typically requires documentation of genetic counseling for BRCA testing. The patient completed pre-test genetic counseling and plans post-test follow-up, satisfying counseling requirements.",81277,"Of the provided CPT options, 81277 most closely corresponds to BRCA-related testing (large rearrangement/BRCA series) and is the best available match for BRCA1/2 testing in this list.",Yes,"Based on UHC BRCA coverage criteria: the patient has a personal history of breast cancer, a close relative with pancreatic cancer, multiple affected maternal relatives, and documented pre-test genetic counseling. These elements satisfy clinical and counseling requirements, supporting coverage.",1997,2700,4697
Case3474,baseline,without_policy,iter3,WGS,The patient information explicitly states whole genome sequencing (WGS) is being ordered.,Yes,UHC WGS/WES criteria are generally directed to pediatric patients with suspected genetic disorders; the patient is 5 years old (pediatric) and therefore meets age-based eligibility for pediatric genomic sequencing.,Yes,"UHC requires ordering/oversight by an appropriate genetics provider (medical geneticist, geneticist, or equivalent). The test was ordered following evaluation by a medical geneticist, satisfying provider requirements.",Yes,"UHC policy supports WGS/WES for pediatric patients with structural congenital anomalies or suspicion of a syndromic genetic etiology; the patient has congenital choanal atresia with concern for an underlying syndromic association, which meets a medical indication in policy.",No,"UHC typically requires prior standard cytogenomic testing (chromosomal microarray) or other recommended first‑line tests before WGS/WES. The record states only a prior karyotype (nondiagnostic) and does not document CMA or other required prior testing, so required prior tests are incomplete.",Yes,"Family history is relevant under UHC criteria; the patient has an older sibling with developmental delay, which is pertinent family history supporting evaluation for a heritable syndrome.",Yes,"UHC requires documentation of pre‑test genetic counseling for genomic sequencing. The record documents pre‑test counseling completed on multiple occasions and planned post‑test follow‑up, meeting counseling requirements.",81425,"The best corresponding CPT among the options for whole genome sequencing is 81425 (genomic sequencing, whole genome analysis and interpretation).",No,"Although age, provider, medical indication (syndrome suspicion), counseling, and family history support WGS, UHC requires completion/documentation of required prior testing (e.g., chromosomal microarray) before approving WGS. Because CMA is not documented as completed, the request does not meet UHC prior‑test requirements and is not covered as submitted.",1982,2176,4158
Case15938,baseline,without_policy,iter3,WGS,WGS (whole-genome sequencing) is explicitly being considered per the patient information.,Yes,"UnitedHealthcare WGS/WES criteria include coverage for neonatal/pediatric patients with suspected genetic disorders; the patient is a 1‑week‑old infant, meeting the age-based pediatric/neonatal indication.",Not Specified,"UHC policies typically require an ordering clinician responsible for care, but the provided information does not state a payer requirement that only a specific specialty (e.g., board‑certified clinical geneticist) must order WGS; neonatologist ordering is not explicitly disallowed in the provided criteria.",Yes,Coverage criteria support WGS when a genetic/metabolic etiology is suspected for an unexplained neonatal presentation (conjugated hyperbilirubinemia/cholestasis); the clinical presentation and family history increase suspicion and meet medical necessity criteria.,No,"UHC generally requires prior appropriate testing (e.g., chromosomal microarray or targeted testing) to be nondiagnostic before WGS except in certain critically ill/rapidly progressive cases; only karyotype (nondiagnostic) is documented and no CMA or other required prior testing is documented.",Yes,"The patient has a relevant family history: a sibling with unexplained developmental regression, which is pertinent to genetic testing eligibility under payer criteria.",No,UHC coverage for WGS typically requires documentation of pretest genetic counseling; no pretest genetic counseling is documented for this patient.,81425,"CPT 81425 corresponds to whole genome sequencing, which matches the requested WGS.",No,"Although age and medical indication are supportive, coverage criteria are not met because required prior testing (e.g., chromosomal microarray/other targeted testing) is not documented as completed and pretest genetic counseling is not documented; therefore coverage criteria are unmet per UHC policy.",1987,1829,3816
Case4067,baseline,without_policy,iter3,WES,"The note explicitly states ""whole exome sequencing (WES) has been ordered.""",Not Specified,"UHC WES coverage criteria do not impose an absolute age cutoff for diagnostic WES; the 5-year-old age is within the range of patients for whom WES is considered, and no age-based exclusion is documented in the provided payer criteria.",Not Specified,The documentation shows referral by a developmental pediatrician; UHC policies typically do not require a specific ordering specialty for WES or do not specify a single required provider type in the provided criteria.,Yes,Patient has significant hypotonia with developmental concern (referred by developmental pediatrician). UHC medical necessity criteria for WES include unexplained developmental delay/neurologic phenotypes (including hypotonia) suggesting a genetic etiology.,No,"UHC coverage requires prior standard first‑tier testing (commonly chromosomal microarray for unexplained developmental delay/ID) before WES. Only a chromosomal karyotype (nondiagnostic) is documented — CMA is not documented, so required prior testing has not been completed.",Yes,"There is a relevant family history (paternal uncle with sudden unexplained death <35), which is considered relevant family history supporting a hereditary etiology in payer criteria for expanded genetic testing.",Not Answerable,"UHC typically expects documentation of pre‑test counseling/consent for WES, but no information about genetic counseling or consent is provided in the patient information, so compliance cannot be determined.",81415,CPT 81415 corresponds to clinical whole exome sequencing (proband or single‑exome) and is the appropriate code for WES.,No,"Although the patient has a qualifying clinical indication (hypotonia/developmental concern) and relevant family history, UHC requires appropriate prior testing (e.g., chromosomal microarray as first‑tier) and documentation of counseling/consent before approving WES. Only a nondiagnostic karyotype is documented and counseling is not documented; therefore coverage criteria are not met.",1970,2004,3974
Case11514,baseline,without_policy,iter3,WES,The clinical note explicitly states whole exome sequencing (WES) has been requested to investigate a genetic cause of the patient's cholestatic liver disease.,Yes,"UnitedHealthcare WES coverage criteria include pediatric patients with suspected genetic disorders; the patient is 10 years old, which meets pediatric age-based eligibility for diagnostic WES.",No,"UHC policy specifies that WES should be ordered by or in consultation with a clinical genetics provider (or documented genetics consult) or meet equivalent provider requirements; the ordering provider is the patient's oncologist and there is no documentation of a genetics consult, so ordering-provider requirements are not satisfied.",Yes,"UHC medical necessity criteria support WES for unexplained, suspected genetic conditions after first-tier testing when phenotype is consistent with a genetically heterogeneous disorder. The patient has unexplained conjugated hyperbilirubinemia/cholestatic liver disease and a nondiagnostic CMA, consistent with a medical indication for WES.",Not Specified,"The record documents a prior nondiagnostic chromosomal microarray (CMA), but payer-specific required prior testing (e.g., targeted gene panel or metabolic testing) for WES in this hepatic presentation is not specified in the provided information.",Yes,"There is a relevant family history: a cousin with an inborn error of metabolism, which supports inherited metabolic disorder consideration and is pertinent to WES eligibility per payer criteria emphasizing family history.",No,"UHC requires documentation of pre-test genetic counseling for WES; the record explicitly states there is no documentation of pre-test genetic counseling, so counseling requirements are not met.",81415,The CPT code that corresponds to clinical whole exome sequencing (proband) is 81415.,No,"Although age and clinical indication are met and CMA was nondiagnostic, UnitedHealthcare requires appropriate ordering/provider documentation (genetics consult or qualified ordering provider) and documented pre-test genetic counseling for WES; those requirements are not fulfilled, so the test is not covered as submitted.",2007,1919,3926
Case11981,baseline,without_policy,iter3,WGS,The note explicitly states that whole genome sequencing (WGS) is being requested.,Yes,"UHC WGS/WES pediatric coverage criteria apply to children with unexplained developmental/motor concerns; age limits are pediatric (<18) and the patient is 9 years old, so age-based eligibility is met.",Yes,"UHC typically requires ordering/clearance by a genetics specialist or appropriate clinician and documentation of pre-test genetic counseling; the record states pre-test discussion with a genetic specialist, meeting provider requirements.",Yes,"Coverage criteria for WGS include unexplained developmental delay/neurologic/motor concerns persisting from infancy. The patient has abnormal tone since infancy and ongoing motor/developmental concerns, which meets a clinical indication.",No,"UHC policies generally require prior appropriate testing (commonly chromosomal microarray and other targeted tests) before WGS; fragile X testing was done and nondiagnostic, but no documentation of prior chromosomal microarray (CMA) is provided, so required prior testing is incomplete.",Not Specified,"While a maternal uncle with a severe immunologic disorder is reported, family history/consanguinity are not specified as required eligibility criteria in the payer's WGS policy for this presentation, and the relative's immunologic disorder is not clearly relevant to the patient's neurodevelopmental indication.",Yes,"UHC requires documentation of pre-test genetic counseling for WGS/WES; the chart documents pre-test discussion with a genetic specialist, satisfying counseling requirements.",81425,CPT 81425 corresponds to clinical whole genome sequencing (WGS).,No,"Although age, indication, provider, and counseling requirements are met and fragile X was performed, UHC typically requires prior CMA (or equivalent) before WGS; CMA is not documented, so full coverage criteria are not met and the test would not be approved under the payer policy.",1992,1579,3571
Case7682,baseline,without_policy,iter3,WES,The clinical note explicitly states 'whole exome sequencing (WES) is being requested.',Yes,"UnitedHealthcare WES coverage commonly applies to pediatric patients with unexplained developmental delay/congenital anomalies; the patient is a 9-year-old child, which meets age-related criteria for pediatric WES.",Yes,"UHC typically requires involvement of or consultation with a genetics provider for WES. Pre-test counseling was completed with a genetic specialist, satisfying ordering/provider requirements.",Yes,"Medical necessity criteria for WES include unexplained multisystem congenital anomalies and developmental delay; this child has multiple congenital abnormalities affecting different organ systems and developmental concerns, meeting clinical indications.",No,UHC policy generally requires prior appropriate cytogenomic testing (commonly chromosomal microarray) before WES for developmental delay/MCAs. Only a nondiagnostic karyotype is documented; CMA is not documented as completed.,Yes,"Family-history criteria are relevant for WES; this patient has a sibling with developmental delay, which is documented and supports testing eligibility.",Yes,"UHC requires documentation of genetic counseling for WES. The record states pre-test counseling was completed with a genetic specialist and post-test follow-up is planned, meeting counseling requirements.",81415,The requested test is whole exome sequencing; CPT 81415 corresponds to clinical exome sequencing.,No,"Although age, medical indication, genetics involvement, and counseling are met, UnitedHealthcare typically requires prior chromosomal microarray (or equivalent cytogenomic testing) before authorization of WES for developmental delay/MCAs; CMA is not documented, so current criteria for coverage are not met.",1973,1595,3568
Case3494,baseline,without_policy,iter3,WES,The patient information explicitly states that whole exome sequencing (WES) is being requested for diagnostic clarification.,Not Specified,"Cigna WES coverage policy does not impose a specific age cutoff for WES; pediatric/neonatal patients are eligible when clinical criteria are met, so no age-based exclusion applies to this 6‑week‑old.",Not Specified,Cigna's WES policy requires appropriate ordering documentation but does not strictly limit ordering to a single specialty in most cases; the record shows a referring pediatrician but the policy does not explicitly restrict orders to a geneticist.,Yes,"Under Cigna criteria WES is medically indicated for unexplained congenital anomalies/evolving complex neurodevelopmental disorder and/or suspected monogenic disorder; this infant has a congenital abnormality involving an organ system and concern for an evolving complex neurodevelopmental disorder, which meets those indications.",No,"Cigna typically requires prior first‑tier testing (e.g., chromosomal microarray for congenital anomalies/developmental delay) before WES; the record states no prior genetic testing has been performed, so required prior testing is not completed.",Yes,"Cigna’s clinical considerations include family history as relevant; the patient has a sibling with dysmorphic features, which is pertinent to WES eligibility.",No,"Cigna requires documentation of pre‑test genetic counseling/consent for WES; the family declined genetic counseling, therefore counseling requirements are not met.",81415,"CPT 81415 corresponds to exome sequencing (whole exome), which matches the requested WES.",No,"Although the clinical indication is met (Q3) and family history is supportive (Q5), Cigna coverage would require prior first‑tier testing (chromosomal microarray) and documented pre‑test genetic counseling; both are missing, so under Cigna policy the WES request would not be covered as submitted.",1975,1777,3752
Case7014,baseline,without_policy,iter3,WGS,The clinical note explicitly states whole genome sequencing (WGS) is being requested.,Not Specified,"UHC genomic sequencing policies do not impose a strict age cutoff for WGS; coverage criteria are based on clinical indications rather than a specific age limit, so no age-based exclusion applies to this 7‑week‑old infant.",Yes,"UHC requires WGS be ordered/authorized by an appropriate provider and pretest genetic counseling/documentation is expected; the case documents referral by neurology and pre‑test counseling by a genetic specialist, meeting provider/ordering requirements.",Yes,"UHC covers WGS for patients with unexplained multiple congenital anomalies or complex neurodevelopmental/neurologic presentations when prior targeted testing is nondiagnostic. The infant has multiple congenital anomalies not fitting a known syndrome and neurologic referral, satisfying a covered clinical indication.",No,"UHC typically requires prior appropriate cytogenetic testing such as chromosomal microarray (CMA) (or documentation why CMA is inappropriate) before WGS. Only a nondiagnostic karyotype is documented; CMA completion is not documented, so required prior testing has not been completed.",Yes,"Family history is documented (maternal aunt with a congenital anomaly). While not determinative, the presence of a relative with a congenital anomaly is relevant to genetic evaluation per UHC criteria.",Yes,"UHC expects pre‑test genetic counseling for comprehensive genomic testing; the record states pre‑test counseling was completed with a genetic specialist, satisfying counseling requirements.",81425,CPT 81425 corresponds to whole genome sequencing (WGS) with analysis/interpretation and is the appropriate code for the requested test.,No,"Although the infant meets clinical indication and counseling/provider requirements, UHC coverage typically requires prior chromosomal microarray (or documentation why it is not appropriate) before WGS. CMA is not documented as completed; therefore, under UHC criteria the WGS request would not meet all prior test requirements and is not covered as submitted.",1983,1925,3908
Case13517,baseline,without_policy,iter3,WES,The clinical note explicitly states whole exome sequencing (WES) was ordered to evaluate for an underlying genetic cause.,Not Specified,UHC WES coverage guidance does not impose a strict age cutoff for exome sequencing; the patient is 16 but age-based limits are not specified in policy.,Not Specified,UHC policies generally require appropriate specialty documentation but do not mandate a single specific ordering specialty for WES; the order from a developmental pediatrician is acceptable and no explicit restrictive ordering-provider requirement is provided in the record.,Yes,"Medical necessity criteria for WES include evaluation of suspected genetic disorders/inborn errors of metabolism and situations with an affected family member. The patient has conjugated hyperbilirubinemia with a sibling whose labs suggest an inborn error, meeting an indication for WES per UHC coverage criteria.",Not Specified,"UHC often requires prior targeted testing (e.g., CMA for isolated developmental delay) in some contexts, but for suspected inborn errors/metabolic disease there is no single universally required prior test documented here. The record notes Fragile X was done, but no other required prior tests are explicitly mandated for this metabolic presentation.",Yes,The patient has a sibling with laboratory abnormalities suggestive of an inborn error of metabolism; family history of an affected first-degree relative is relevant and supports WES per coverage criteria.,Yes,"UHC requires documentation of genetic counseling for WES; pre-test counseling was completed with a genetic counselor and post-test counseling is planned, satisfying counseling requirements.",81415,CPT 81415 corresponds to exome sequencing (WES) with analysis and interpretation; this is the appropriate code for the requested test.,Yes,"Based on UHC coverage principles: the patient has a clinical suspicion of a genetic/inborn error (conjugated hyperbilirubinemia) plus a sibling with suggestive labs (affected family member), pre-test genetic counseling was completed, and WES is an appropriate diagnostic modality for suspected metabolic/genetic disorders. These factors meet medical necessity criteria for coverage.",1991,2386,4377
Case14127,baseline,without_policy,iter3,WES,The case text explicitly states that whole exome sequencing (WES) is being pursued to investigate an underlying genetic etiology.,Not Specified,"UHC WES coverage criteria do not impose a strict age cutoff; the patient is 17 but the payer policy applies across pediatric/adult presentations, so no age-based exclusion or specific age requirement is specified.",Yes,"UHC typically requires that testing be ordered/coordinated by an appropriate genetics provider; here a medical geneticist is coordinating the testing, which satisfies ordering/provider requirements in the payer policy.",Yes,"UHC WES criteria include unexplained global developmental delay/intellectual disability and similar neurodevelopmental disorders as accepted indications. The patient has lifelong GDD with cognitive and adaptive deficits, meeting the medical indication criteria.",No,"UHC generally requires prior first‑tier testing (chromosomal microarray as first‑line for unexplained GDD/ID). Only nondiagnostic FISH is documented; no chromosomal microarray (CMA) or other required prior testing is documented, so required prior tests appear incomplete.",Yes,"Family history is relevant to eligibility under UHC criteria; the patient has a sibling with early‑onset epileptic encephalopathy (onset before age 3), which is pertinent family history supporting genetic evaluation.",Yes,"UHC requires documentation of pre‑test genetic counseling and appropriate post‑test plans for WES. The patient had pre‑test counseling with a genetic counselor and will return for post‑test counseling, meeting counseling requirements.",81415,"The CPT code corresponding to proband whole exome sequencing (WES) is 81415, which best matches the requested test.",No,"Although the indication, provider, and counseling meet UHC criteria, required prior testing (notably chromosomal microarray as first‑tier testing for unexplained GDD/ID) is not documented. Per UHC coverage rules, lack of documented required prior testing means WES is not covered at this time.",2003,1989,3992
Case15820,baseline,without_policy,iter3,CMA,The clinical note explicitly states chromosomal microarray (CMA) has been ordered to evaluate for copy number variants in a patient with developmental delay and intellectual disability.,Not Specified,Cigna's CMA coverage is driven by the clinical indication (unexplained developmental delay/intellectual disability) rather than an age cutoff; no age-based exclusion is specified and the patient is 31 years old.,Not Specified,Cigna's CMA policy does not impose a specific ordering-provider specialty requirement in routine practice; the record does not indicate any specialty-based restriction is applicable.,Yes,The patient has unexplained developmental delay and intellectual disability without a suspected specific syndrome — a stated medical necessity indication in Cigna's CMA coverage criteria.,Not Specified,"Cigna allows CMA as a first‑line test for unexplained DD/ID; there are no required prior genetic tests that must be completed before CMA in this clinical scenario, and the record reports no prior testing.",Not Specified,"Family history criteria relevant to CMA (e.g., close relatives with CNV-associated conditions) are not documented; the noted family history (mother with early breast cancer) is relevant to hereditary breast cancer testing (BRCA) but not to CMA eligibility per policy.",Yes,"Cigna expects documentation of genetic counseling for genomic testing; the record documents multiple pre‑test counseling sessions with a genetic counselor and planned post‑test follow‑up, meeting that requirement.",Not Specified,None of the provided CPT options clearly correspond to chromosomal microarray reporting; CMA is typically reported with microarray-specific molecular cytogenetic codes that are not listed among the choices.,Yes,"Per Cigna coverage for CMA, the patient meets medical necessity (unexplained DD/ID), has documented pre‑test genetic counseling, no age restriction applies, and therefore CMA is covered for this presentation.",1984,2919,4903
Case13675,baseline,without_policy,iter3,WGS,"The clinical note explicitly states ""whole genome sequencing (WGS) is being pursued for diagnostic clarification.""",Yes,UHC WES/WGS coverage criteria are age‑sensitive and allow testing for pediatric/infant-onset suspected genetic disorders; the patient is an 8‑week‑old infant and therefore meets the pediatric/early‑onset age criterion.,Yes,"UHC permits ordering by treating specialists in the neonatal/critical care setting (genetics consultation preferred but not always required); the order is placed by a neonatologist and planned follow‑up is by the neonatal team, which satisfies provider requirements for NICU/pediatric indications.",Yes,"UHC medical‑necessity criteria for WGS include unexplained congenital anomalies or early‑onset multisystem/sensory deficits; this infant has significant congenital hearing and/or visual impairment identified in early infancy, meeting a defined clinical indication.",No,"UHC typically requires prior targeted/first‑line cytogenetic testing (e.g., chromosomal microarray) or other indicated prior tests before WGS for non‑critically ill patients; only nondiagnostic FISH is documented and there is no record of prior chromosomal microarray (CMA), so required prior testing has not been completed.",Not Specified,"While a paternal history of long QT is documented and relevant to interpretation, UHC WGS eligibility criteria do not generally require family history/consanguinity as a formal eligibility condition for WGS, so family history is supportive but not a specified criterion.",No,"UHC policies commonly require documentation of pre‑test genetic counseling for WES/WGS; there is no documentation of pre‑test counseling in the record, so the counseling requirement is not met.",81425,"Among the provided CPT options, 81425 corresponds to whole genome sequencing (WGS) comprehensive sequence analysis/interpretation.",No,"Although age, ordering provider, and medical indication support coverage, required prerequisites are not met (no documented chromosomal microarray/prior required testing and no pre‑test genetic counseling). Under UHC coverage rules these unmet requirements would make WGS not covered at this time until prerequisites and counseling are documented.",1994,2220,4214
Case2162,baseline,without_policy,iter3,WGS,The clinical note explicitly states 'whole genome sequencing (WGS)' was ordered.,Not Specified,BCBS_FEP coverage for genomic sequencing is applied by clinical indication rather than strict age cutoffs in typical policy language; no payer-imposed age restriction is specified for WGS in this context.,Not Specified,"Typical BCBS_FEP policy does not mandate a specific ordering provider specialty for WGS beyond a qualified clinician/genetics team; the provided information does not state a required specialty, so ordering-provider requirement is not specified.",Yes,"BCBS_FEP criteria consider WES/WGS medically necessary for unexplained multiple congenital anomalies or multisystem congenital findings. The infant has multiple congenital anomalies affecting multiple organ systems, which meets that indication.",No,"BCBS_FEP commonly requires first‑tier testing (e.g., chromosomal microarray) prior to WES/WGS; only Fragile X testing (nondiagnostic) is documented and chromosomal microarray is not reported, so required prior testing has not been completed.",Yes,"The family history includes an older sibling with autism spectrum disorder. While not required, BCBS_FEP recognizes relevant family history as supportive for genetic evaluation and it is present here.",Yes,"BCBS_FEP policies generally require documentation of pre-test genetic counseling for genomic sequencing; the record documents pre-test counseling and planned post-test follow-up, satisfying counseling requirements.",81425,"Among the provided CPT options, 81425 corresponds to large-scale clinical genomic sequencing (exome/genome level) and is the best match for a WGS request in the absence of a specific WGS-only code in the choices.",No,"Although clinical indications and counseling requirements are met, BCBS_FEP coverage requires appropriate prior testing (notably chromosomal microarray) before WGS; because CMA is not documented as completed, the request does not satisfy all coverage prerequisites and would not be approved as submitted.",1965,2359,4324
Case7376,baseline,without_policy,iter3,WES,The clinical note explicitly states 'whole exome sequencing (WES) has been ordered for diagnostic clarification.',Not Specified,UHC WES coverage criteria do not impose a strict upper- or lower-age cutoff in typical policy language; age-based eligibility is not specified for WES in this adult patient (73 y/o).,Yes,"UHC allows ordering by a treating physician when medical necessity is documented; the test was referred by a neurologist and pre-test counseling was completed by a genetic specialist, meeting provider/counseling expectations.",Yes,"UHC considers WES medically necessary for unexplained, significant medical conditions suspected to be genetic when prior targeted testing is nondiagnostic; the patient has a major unexplained organ-system abnormality and prior FISH testing was nondiagnostic.",Not Specified,"UHC policies typically require prior targeted testing as clinically appropriate (e.g., gene-specific tests, panels, CMA depending on phenotype), but the specific prior-test requirements for this adult single-organ-system presentation are not explicitly defined here; only nondiagnostic FISH is documented.",Yes,"UHC guidance notes family history can be relevant to genetic testing decisions; the patient reports a sister with triple-negative breast cancer, which is a pertinent family history for hereditary cancer predisposition and may support testing considerations.",Yes,"UHC commonly requires or strongly recommends pre-test genetic counseling for WES; the record states pre-test counseling was completed with a genetic specialist, satisfying counseling requirements.",81415,CPT 81415 corresponds to exome sequencing (whole exome sequencing) diagnostic testing; this best matches the ordered WES.,Yes,"Based on UHC criteria applied to this case: adult with unexplained major abnormality suspected to be genetic, prior targeted testing (FISH) nondiagnostic, ordering physician involvement and documented pre-test genetic counseling — WES meets medical necessity and is covered.",1983,2094,4077
Case11124,baseline,without_policy,iter3,WES,The clinical note explicitly states 'whole-exome sequencing (WES) has been ordered.',Not Specified,UHC genomic sequencing criteria focus on clinical indications (developmental delay/congenital anomalies) rather than a strict age cutoff; no age-based exclusion or specific age threshold is documented in the provided information.,Not Specified,The record shows referral by an oncologist but UHC policy does not universally mandate a single specialty for ordering WES in the provided policy context; no explicit ordering-provider specialty requirement is documented in the patient information.,Yes,"UHC covers WES for unexplained developmental delay/possible hereditary neurodevelopmental disorders; the infant presents with developmental delay and a family history raising concern for a hereditary etiology, meeting clinical indication criteria.",No,UHC typically requires prior chromosomal microarray (CMA) or equivalent cytogenomic testing before WES for developmental delay; only prior FISH (nondiagnostic) is documented and no CMA result is provided.,Yes,The patient has an affected sibling with childhood hearing impairment; family history of a similar phenotype is relevant and cited by UHC-type criteria as supportive for comprehensive exomic testing.,Yes,"UHC requires pre-test genetic counseling for clinical genomic sequencing; the record documents pre-test counseling completed and post-test counseling planned, satisfying counseling requirements.",81415,CPT 81415 corresponds to clinical exome sequencing (proband-only) and is the appropriate code for WES under UHC coverage practices.,No,"Although the infant meets clinical indication and counseling requirements, coverage is not supported because required prior cytogenomic testing (chromosomal microarray) is not documented; per UHC criteria WES is not covered until prior testing requirements are met.",1978,1617,3595
Case8051,baseline,without_policy,iter3,WES,The clinical note explicitly states whole exome sequencing (WES) is being ordered to evaluate the infant's congenital cardiac anomaly and possible syndromic association.,Not Specified,"BCBS_FEP WES coverage criteria are not age‑restricted in practice; policies address clinical indications rather than a strict age cutoff, and the patient (5 weeks) does not conflict with any age limitations.",Not Specified,"BCBS_FEP WES rules focus on clinical indications and documentation (including genetic counseling) rather than mandating a specific ordering specialty; the record shows a family medicine physician ordered the test and pre‑test counseling was completed, but the policy does not explicitly require a particular specialty to place the order.",Yes,"Under BCBS_FEP coverage criteria WES is considered medically necessary for unexplained major congenital anomalies or suspected syndromic genetic conditions when used to clarify etiology; this infant has a major congenital cardiac anomaly with concern for syndromic association, meeting a defined clinical indication.",No,"BCBS_FEP WES criteria generally require prior appropriate cytogenomic testing such as chromosomal microarray (CMA) or other targeted tests before WES for congenital anomalies. Only a nondiagnostic FISH is documented; no CMA or equivalent prior test is documented, so required prior testing is incomplete.",Yes,"Family history that is potentially relevant is documented (mother with short stature raising concern for a growth‑related genetic condition), which is a pertinent family history under BCBS_FEP criteria for evaluation of a possible syndromic or heritable condition.",Yes,"BCBS_FEP requires documentation of pre‑test genetic counseling for WES; the record states pre‑test genetic counseling was completed and post‑test follow‑up is planned, satisfying counseling requirements.",81415,"The requested test is proband whole exome sequencing (single proband exome), which corresponds to CPT code 81415 (clinical exome sequencing, proband only).",No,"Although the clinical indication and genetic counseling meet BCBS_FEP criteria, coverage is contingent on completion of required prior testing (eg, chromosomal microarray) for congenital anomalies. Only nondiagnostic FISH is documented and no CMA is shown; therefore the prior‑test requirement is unmet and the request would not meet BCBS_FEP coverage requirements as presented.",1987,1863,3850
Case19905,baseline,without_policy,iter3,WES,The clinical note explicitly states the patient is being considered for whole exome sequencing (WES).,Yes,"UHC WES coverage criteria are focused on pediatric patients with unexplained developmental delay/multiple congenital anomalies; the patient is 3 years old, which satisfies pediatric age-based eligibility.",Yes,"UHC generally requires an appropriate specialist to order WES (genetics, pediatric subspecialist). The test was referred by a developmental pediatrician, which meets ordering-provider requirements.",Yes,"UHC medical necessity criteria support WES for patients with multiple congenital anomalies and developmental concerns; the patient has multiple congenital anomalies and developmental referral, meeting indication criteria.",No,"UHC typically requires prior chromosomal microarray (CMA) (and other targeted testing as appropriate) before WES. Only a nondiagnostic karyotype is documented; there is no documentation of prior CMA, so required prior testing has not been completed.",Not Specified,"UHC WES criteria do not generally require a specific family history or consanguinity to qualify; although a maternal history of long QT is documented, family-history-based criteria for WES eligibility are not specified in this case.",No,"UHC coverage and best-practice requirements expect documentation of genetic counseling (pre-/post-test) for WES. The record states no genetic counseling has been conducted, so counseling requirements are not met.",81415,CPT 81415 corresponds to clinical exome sequencing (WES) interpretation/reporting and is the appropriate code for WES.,No,"Although age, provider, and clinical indication meet UHC criteria, required prerequisites (documentation of prior CMA or other required prior testing and documented genetic counseling) are missing; therefore under UHC criteria the test is not covered at this time.",1955,1560,3515
Case10850,baseline,without_policy,iter3,WGS,The clinical note explicitly states whole genome sequencing (WGS) has been ordered.,Yes,"UHC coverage for WES/WGS is defined for pediatric patients with unexplained global developmental delay/intellectual disability; the patient is 13 years old, meeting the pediatric age-based eligibility.",Yes,"UHC policies require ordering by a qualified clinician; the test was ordered by a developmental pediatrician (a board‑level treating physician/specialist), which satisfies ordering provider requirements.",Yes,"UHC lists unexplained global developmental delay/intellectual disability as a covered indication for WES/WGS; the patient has global developmental delay, meeting the clinical indication.",No,UHC generally requires prior first‑tier testing (chromosomal microarray and other directed testing as appropriate) before WES/WGS; only nondiagnostic FISH was performed and no CMA or other required prior tests are documented.,Yes,"Family history is relevant under UHC criteria as supportive evidence; the record documents an aunt with dysmorphic features (second‑degree relative), so relevant family history is present.",Yes,"UHC requires/encourages pre‑test genetic counseling for WES/WGS; the family completed pre‑test counseling and plans post‑test follow‑up, meeting counseling requirements.",81425,81425 corresponds to whole genome sequencing (germline) CPT coding and best matches the ordered WGS.,No,"Although age, clinical indication, provider, counseling, and family history meet UHC criteria, required prior testing (notably chromosomal microarray/first‑tier testing) is not documented; per UHC coverage policy absence of required prior tests makes WGS not eligible for coverage at this time.",1975,1609,3584
Case19321,baseline,without_policy,iter3,WES,The note explicitly states whole exome sequencing (WES) is being pursued to investigate a possible genetic etiology for the patient's neurodevelopmental disorder.,Not Specified,UHC WES policies generally apply to individuals with unexplained neurodevelopmental disorders but do not impose a strict single age cutoff in the policy text; the patient is pediatric (1 year) which is within typical pediatric indications but no explicit age-based exclusion or specific age threshold is specified.,Yes,"UHC permits ordering by the treating specialist when medically appropriate; the test was ordered by a neurologist (an appropriate specialist), and pre-test genetics counseling was documented, meeting provider-related requirements.",Yes,"UHC criteria support WES for unexplained neurodevelopmental disorders/possible autism spectrum disorder and multiple congenital anomaly syndromes when a genetic etiology is suspected; the patient has complex neurodevelopmental disorder with ASD features and a suggestive family history, meeting medical indication criteria.",Yes,"UHC typically requires prior standard testing such as chromosomal microarray (CMA) before WES; the record states prior CMA testing was nondiagnostic, satisfying this prerequisite.",Yes,"Family history criteria are relevant for genetic evaluation; the patient has a maternal aunt with multiple congenital anomalies, which is a relevant family history supportive of genetic testing per UHC criteria.",Yes,UHC commonly requires documentation of pre-test genetic counseling for WES; the record indicates pre-test genetic counseling was completed and post-test follow-up is planned.,81415,"CPT 81415 corresponds to whole exome sequencing (clinical exome sequencing with interpretation), which matches the requested WES.",Yes,"Based on UHC WES coverage criteria: appropriate medical indication (pediatric neurodevelopmental disorder/ASD features), required prior testing (CMA) completed and nondiagnostic, appropriate ordering provider (neurologist), and documented pre-test genetic counseling — the request meets coverage criteria.",1982,1653,3635
Case2496,baseline,without_policy,iter3,WES,The case explicitly states 'whole exome sequencing (WES)' is being requested for prenatal evaluation.,Not Specified,UHC WES coverage criteria do not impose a strict patient age cutoff; this is a prenatal/fetal request at 32 weeks and policy language does not specify an age restriction for WES.,No,"UHC typically requires WES be ordered by or in consultation with an appropriate genetics provider and documented pre‑test genetics involvement; the ordering provider is a neonatologist and no genetics consult or documented counseling is reported, so ordering/provider requirements are not met.",Yes,"UHC permits WES when there is a suspected single‑gene disorder or unexplained fetal findings not resolved by targeted testing; this fetus has parental consanguinity, family history of sudden unexplained death, prior nondiagnostic targeted testing (FISH), and concern from fetal imaging → meets a clinical indication for WES.",No,"UHC prenatal WES policies generally require prior standard cytogenomic testing (e.g., chromosomal microarray/karyotype) to be non‑diagnostic before WES; only FISH (nondiagnostic) was performed, and no CMA result is documented.",Yes,"UHC considers family history and consanguinity relevant to WES eligibility; the case documents parental consanguinity and a sibling with sudden unexplained death <35, both relevant.",No,"UHC policies require documented pre‑test genetic counseling for WES; the record states no genetic counseling has been completed, so counseling requirements are not met.",81415,CPT 81415 corresponds to clinical whole exome sequencing (proband/exome sequencing) and is the appropriate code for WES.,No,"Although the clinical indications (consanguinity, family history, nondiagnostic targeted testing and fetal concern) support WES, UHC coverage requires prior cytogenomic testing (e.g., CMA) and documented pre‑test genetics involvement/order by appropriate genetics provider. Those required elements are not present, so the test would not meet coverage criteria as submitted.",1995,1874,3869
Case6867,baseline,without_policy,iter3,BRCA1/2,The note explicitly states she presents for BRCA1 and BRCA2 testing.,Not Specified,BCBS FEP hereditary cancer testing coverage is driven by personal and family cancer history criteria rather than a strict cutoff based solely on the proband's current age; the record gives the patient's age (50) but no policy-specific age exclusion is indicated.,Yes,"BCBS FEP requires the test be ordered by an appropriate licensed provider; the order was placed by a nurse practitioner (an authorized ordering clinician) and pre-test counseling was performed by a genetic counselor, meeting ordering/provider expectations.",Yes,"Medical necessity criteria include a personal history of breast cancer and/or a first-degree relative with cancer types associated with BRCA variants (mother with breast cancer at 50; brother with metastatic prostate showing intraductal features), which meet BCBS FEP indications for BRCA testing.",Not Specified,BCBS FEP does not mandate prior genetic testing or tumor testing for routine full BRCA1/2 germline analysis in this clinical scenario; no specific prior tests are documented as required.,Yes,Family history criteria are relevant for BRCA testing under the payer policy and are met here: first-degree relatives include a mother with breast cancer at age 50 and a brother with metastatic prostate with intraductal features (BRCA-associated).,Yes,"BCBS FEP expects documentation of pre-test genetic counseling for hereditary cancer testing; the patient had multiple pre-test counseling visits with a genetic counselor, satisfying counseling requirements.",81162,The CPT code corresponding to full sequence analysis of BRCA1 and BRCA2 (germline BRCA testing) is 81162.,Yes,Under BCBS FEP hereditary cancer testing criteria the combination of the patient's personal history of breast cancer plus relevant first‑degree relatives (mother with breast cancer at 50; brother with metastatic prostate with intraductal features) and documented pre‑test counseling supports medical necessity and coverage for BRCA1/2 testing.,1986,2441,4427
Case1130,baseline,without_policy,iter3,WES,The patient record explicitly states 'whole exome sequencing (WES) to assess for an underlying genetic etiology.',Not Specified,UHC exome coverage criteria do not impose a strict age cutoff for WES; the patient is 68 but age-based limits are not specified in the policy for WES in adults with suspected genetic disease.,Not Specified,"UHC typically requires an appropriate ordering clinician and documentation but does not mandate a single specific specialty (e.g., must be a geneticist) for ordering WES; the record shows cardiology referral and genetics involvement but the policy does not specify a restrictive ordering-provider requirement.",Yes,"UHC covers WES when there is a suspected genetic etiology for unexplained, persistent neurologic disease such as refractory or unexplained seizures and prior targeted testing is nondiagnostic. The patient has persistent seizures and prior FISH testing was nondiagnostic, meeting the medical indication.",Not Specified,"UHC coverage criteria require appropriate prior diagnostic evaluation but do not universally mandate a single specific prior test in all clinical scenarios. The patient had prior nondiagnostic FISH; policy allows WES when prior testing is nondiagnostic or phenotype is broad, so no single required prior test is clearly specified for this scenario.",Not Specified,"UHC WES criteria do not generally require specific family history or consanguinity for coverage. Although a relative has ovarian/fallopian/peritoneal cancer, that family history is more relevant to BRCA testing than to WES and is not a stated WES eligibility requirement.",Yes,"UHC requires documentation of pre- and/or post-test genetic counseling for large-panel/exome testing; the patient has seen a genetic counselor multiple times with planned post-test follow-up, satisfying counseling requirements.",81415,"CPT 81415 corresponds to exome sequencing (proband/single exome), which matches the requested WES.",Yes,"Based on UHC criteria: the patient has persistent unexplained seizures (clinical indication), prior targeted testing (FISH) was nondiagnostic, documented genetic counseling is present, and no disqualifying age or ordering-provider restrictions apply—therefore WES is covered.",1989,1961,3950
Case5303,baseline,without_policy,iter3,BRCA1/2,The patient was referred specifically for BRCA1 and BRCA2 testing; that is the explicit test requested.,Not Specified,"UHC BRCA coverage criteria do not impose a strict age cutoff for testing; eligibility is driven by personal/family cancer history rather than age alone, and no age-based restriction is indicated in the provided information.",Not Specified,UHC policies generally require an ordering provider but do not limit BRCA testing to a specific specialty in the provided criteria; the referral from neurology does not by itself violate any specified ordering-provider requirement in the payer criteria supplied.,No,"UHC BRCA medical-necessity criteria require a personal history of or a family history strongly suggestive of BRCA-related cancers (e.g., breast, ovarian, related male breast, pancreatic, or metastatic prostate cancer). The patient has a major non-breast/ovarian organ system abnormality and a brother who died suddenly <35, which are not BRCA-related indications per the payer criteria.",Not Specified,"There are no payer-specified prior testing requirements (e.g., single-site familial variant testing) documented for BRCA in this case; the record only states no prior genetic testing was done.",No,"UHC BRCA criteria specify relevant family history of BRCA-associated cancers. The only family history provided is a brother with sudden unexpected death <35, which is not a BRCA-associated cancer history, so the patient does not meet family-history criteria.",No,"UHC commonly requires documentation of pre-test genetic counseling for BRCA testing. The patient had no pre-test genetic counseling, so counseling requirements are not met.",Not Specified,"The request is for BRCA1/2 testing, but none of the CPT options provided clearly correspond to standard BRCA single-gene sequencing codes; therefore a precise CPT from the supplied list cannot be selected.",No,"Based on UHC BRCA coverage criteria: the patient lacks a personal or family history of BRCA-associated cancers, pre-test genetic counseling was not documented, and no prior indicated testing was done—therefore BRCA1/2 testing is not supported as medically necessary and is not covered.",1960,1962,3922
Case7447,baseline,without_policy,iter3,WGS,The cardiologist explicitly ordered whole genome sequencing (WGS) for the fetus.,Not Specified,BCBS_FEP WGS coverage criteria are based on clinical presentation and prior testing rather than patient age; no age-based exclusion or requirement is specified for prenatal WGS in the provided policy context.,Not Specified,The patient info states the cardiologist ordered the test but the documentation does not state any payer-specific ordering-provider restriction; BCBS_FEP policies typically require an appropriate ordering clinician and genetic counseling involvement but do not universally limit ordering to a single specialty in the provided scenario.,No,"Under BCBS_FEP WGS/WES prenatal criteria, testing is generally reserved for fetuses with multiple congenital anomalies or when standard genetic testing is nondiagnostic and results would affect management. This case documents an isolated severe congenital heart defect (single-organ anomaly) without prior microarray results, so the specified medical-necessity indications are not met.",No,"BCBS_FEP prenatal WGS coverage generally requires prior standard testing (eg, karyotype and chromosomal microarray) to be non-diagnostic before WGS; only fragile X testing was reported (nondiagnostic) and there is no documentation of a chromosomal microarray or karyotype.",Not Specified,Family history of adult-onset breast cancer in a maternal aunt is noted but BCBS_FEP WGS prenatal criteria do not specify that this family history is relevant to prenatal WGS eligibility for a fetal structural cardiac anomaly.,No,"BCBS_FEP generally requires pre-test genetic counseling/documentation for high-complexity genomic testing; here there is no documentation of pre-test genetic counseling, so counseling requirements are not met.",81425,"CPT 81425 corresponds to whole genome sequencing (germline) with interpretation and report, which best matches the ordered WGS.",No,"Based on BCBS_FEP coverage rules: (1) the indication (isolated severe CHD) does not meet the specified prenatal WGS medical-necessity criteria that typically require multiple anomalies or nondiagnostic prior standard testing, (2) required prior testing (chromosomal microarray/karyotype) is not documented, and (3) pre-test genetic counseling is not documented. Therefore the request does not meet coverage criteria.",1972,2175,4147
Case16126,baseline,without_policy,iter3,BRCA1/2,Patient information explicitly states BRCA1 and BRCA2 testing has been ordered.,Not Specified,BCBS_FEP BRCA coverage is driven by personal/family cancer history and guideline-based criteria rather than a strict lower age cutoff; no explicit age-based exclusion for infants is specified in policy.,Not Specified,BCBS_FEP policies require an appropriate ordering provider/medical documentation but do not universally restrict BRCA orders to a specific specialty in the policy text provided; the record shows a gynecologist ordered testing but the policy does not explicitly require or prohibit that specialty.,No,"BCBS_FEP covers BRCA testing for individuals meeting personal or strong family-history criteria for hereditary breast/ovarian cancer per guidelines. This 6-week-old infant has multiple congenital anomalies but no provided personal or family history of BRCA-associated cancers, so medical indication per policy is not met.",Not Specified,"BCBS_FEP BRCA coverage does not require prior diagnostic tests (the prior nondiagnostic FISH here is unrelated), and the policy does not specify required prior testing that must be completed before BRCA sequencing.",No,"BCBS_FEP BRCA coverage depends on family history of breast/ovarian cancer or known familial mutation. Although consanguinity is reported, no family history of BRCA-related cancers or a known pathogenic familial BRCA variant is provided, so relevant family-history criteria are not met.",Yes,"BCBS_FEP and guideline-based testing typically require or strongly recommend pre-test genetic counseling. The record documents pre-test counseling and planned post-test follow-up with a genetic counselor, meeting counseling requirements.",Not Specified,"The provided CPT options do not include the common BRCA-specific CPT codes typically used for full BRCA1/2 sequence analysis; none of the listed codes clearly correspond to BRCA1/2 sequencing in standard coding, so a best-match code is not specified from the given options.",No,"Under BCBS_FEP coverage criteria BRCA1/2 testing is covered only when guideline-based personal or family-history indications or a known familial mutation exist. This infant lacks those indications (no personal/family BRCA-related cancer history or known familial pathogenic variant), so testing is not medically necessary and would not be covered.",1967,2106,4073
Case4512,baseline,without_policy,iter3,WGS,The patient information explicitly states whole genome sequencing (WGS) is being pursued to identify a genetic etiology.,Not Specified,BCBS_FEP WES/WGS coverage criteria do not impose a strict age cutoff for diagnostic WGS; the patient is 21 but policy language typically addresses clinical indications rather than a specific age limit.,Not Specified,The case does not state the ordering provider specialty and BCBS_FEP policies generally do not universally restrict ordering to a single specialty in all situations; specific ordering-provider requirements are not specified in the provided information.,Yes,"BCBS_FEP coverage criteria consider WGS medically indicated for individuals with major congenital anomalies or suspected genetic disorder—this patient has a major congenital cardiac anomaly present since birth and a suggestive family history, satisfying clinical indication.",No,"BCBS_FEP policies commonly require prior appropriate testing (e.g., CMA and/or targeted gene testing) before WGS unless specific exceptions apply; the record states no prior genetic testing has been performed.",Yes,"The patient has a sibling with a brief resolved unexplained event (cyanosis/pallor/irregular breathing), which is relevant family history supporting a potential heritable predisposition under BCBS_FEP criteria.",Yes,BCBS_FEP typically requires pre-test counseling for comprehensive genomic testing; the record documents that pre-test counseling was completed with a genetic counselor and a post-test visit is planned.,81425,CPT 81425 corresponds to clinical whole genome sequencing (WGS) and best matches the requested test.,No,"Although the patient meets clinical indication and counseling requirements and has relevant family history, BCBS_FEP generally requires prior appropriate testing (e.g., CMA and/or targeted gene panels) before approving WGS; because no prior genetic testing was performed, coverage is not supported at this time.",2006,2210,4216
Case1778,baseline,without_policy,iter3,WES,The patient information explicitly states that whole exome sequencing (WES) has been requested for diagnostic clarification.,Not Specified,"Most commercial WES policies do not impose a strict single age cutoff (many apply to both pediatric and adult patients or specify ‘pediatric’ broadly). The patient is 14 (pediatric), but the provided information does not cite a payer policy that specifies an age-based exclusion or requirement, so age-based criteria are not specified in the case data.",Not Specified,No ordering-provider specialty or credential information is given in the patient data and many payer WES policies either do not specify strict provider-type requirements or vary by payer. The chart does not state any required provider credential is present or absent.,No,"Typical payer coverage criteria for WES require a patient to have a suspected genetic disorder not explained by prior testing and commonly require either multiple congenital anomalies, unexplained developmental delay/intellectual disability, or other syndromic features. This patient has an isolated ocular coloboma (single-organ finding) with no other syndromic features noted, so she does not meet commonly specified medical-indication criteria for diagnostic WES.",No,"Many payer WES policies require prior appropriate targeted testing such as chromosomal microarray (CMA) and/or other recommended targeted tests before WES. The record states prior FISH testing was nondiagnostic, but FISH is not equivalent to CMA and CMA was not documented, so required prior testing has not been completed.",Not Answerable,"The patient information contains no family history or consanguinity data. Because family-history–based criteria are commonly relevant to WES eligibility, but no such information is provided here, this cannot be determined from the supplied facts.",Not Answerable,"Pre-test genetic counseling is commonly required by many payer policies for WES, but the provided information does not state whether genetic counseling has occurred or who counseled the patient, so this requirement cannot be confirmed from the record.",81415,The requested test is whole exome sequencing; the CPT code that corresponds to clinical exome sequencing in this set of options is 81415.,No,"Per usual payer medical policy criteria applied to this case: the patient has an isolated ocular coloboma (not the typical multi-system or neurodevelopmental presentation that triggers WES coverage), required prior testing (notably chromosomal microarray) was not documented (only FISH was done), and genetic counseling/other ordering requirements were not documented. Based on these deficiencies relative to common payer WES coverage rules, the test would not be covered.",1935,1850,3785
Case14155,baseline,without_policy,iter3,WGS,The clinical note explicitly states whole genome sequencing (WGS) has been requested.,Not Specified,Cigna's WES/WGS criteria do not impose strict age cutoffs for testing in neurodevelopmental disorders; the patient is a child (7 years) but age-based restrictions are not specified in the policy.,Not Specified,"Cigna policies typically require an appropriate ordering clinician, but do not universally restrict orders to a single specialty in all cases. The documentation shows neurology as the ordering provider; the policy does not explicitly mandate only genetics specialists for all WGS orders, so ordering-provider requirements are not specifically determinable from the provided information.",Yes,"Cigna's coverage criteria list unexplained neurodevelopmental disorders (including autism spectrum disorder/developmental delay) as appropriate indications for WES/WGS; the patient has ASD, which meets the clinical indication criterion.",No,Cigna requires prior appropriate genetic testing (commonly chromosomal microarray and other indicated tests such as Fragile X or targeted gene panels) to be non-diagnostic before WES/WGS; the patient has had no prior genetic testing.,Not Specified,"While family history can be relevant, Cigna's core eligibility criteria for WGS focus on the proband's clinical presentation and prior testing. The presence of a maternal uncle with an immunologic disorder is documented but the policy does not define a family-history requirement that changes eligibility in this case.",No,"Cigna's policy requires pre-test genetic counseling as part of WES/WGS coverage criteria; the family declined pre-test genetic counseling, so this required element is not met.",81425,"CPT 81425 corresponds to whole genome sequence analysis, which matches the requested WGS.",No,"Although the patient's diagnosis (ASD) meets clinical indication for WGS, coverage criteria (Cigna) require prior appropriate genetic testing be non-diagnostic and pre-test genetic counseling; the patient has no prior genetic testing and declined counseling, so policy prerequisites are not met and the test would not be covered.",1989,1807,3796
Case13406,baseline,without_policy,iter3,WGS,The clinical note explicitly states whole genome sequencing (WGS) has been ordered by a medical geneticist.,Not Specified,"UHC comprehensive genomic sequencing policies do not impose a strict single age cutoff; indications (e.g., developmental delay, congenital anomalies, critically ill neonate) are clinical rather than age-limited, so no discrete age-based eligibility criterion is specified.",Yes,"UHC policies require ordering by a qualified provider (e.g., medical geneticist or other appropriate specialist). The test was ordered by a medical geneticist, so ordering-provider requirements are met.",Yes,"UHC considers comprehensive genomic sequencing medically necessary for individuals with global developmental delay or neurodevelopmental disorders when prior testing is nondiagnostic. The infant presents with global developmental delay, meeting the clinical indication.",Yes,"UHC generally requires prior standard testing (e.g., chromosomal microarray) before WES/WGS for developmental delay. Chromosomal microarray was previously performed and was nondiagnostic, satisfying the prior test requirement.",Not Specified,UHC WGS criteria do not generally require family history or consanguinity as a mandatory eligibility element; the provided family history (sibling BRUE-like event) is noted but family-history criteria are not specifically required in the policy.,Yes,"UHC requires documentation of genetic counseling (pre-test). Pre-test counseling was completed and post-test follow-up with a genetic counselor is planned, meeting counseling requirements.",81425,The ordered test is whole genome sequencing; CPT 81425 corresponds to whole genome sequence analysis/interpretation and is the appropriate code.,Yes,"Under UHC comprehensive genomic sequencing policy the criteria are met: appropriate clinical indication (GDD), required prior testing (nondiagnostic CMA) completed, ordered by a medical geneticist, and pre-test genetic counseling documented — therefore WGS is covered.",2004,2021,4025
Case3581,baseline,without_policy,iter3,BRCA1/2,The case states 'BRCA1 and BRCA2 testing has been ordered' — therefore BRCA1/2 testing is explicitly requested.,Not Specified,Cigna BRCA coverage is driven by personal/family cancer history and not by a strict age cutoff; no payer age-based eligibility criterion is applicable here.,Not Specified,"Cigna policies specify clinical indications for BRCA testing but do not limit ordering to a particular provider specialty in the policy language provided; the record only notes a cardiologist ordered testing, which is not itself a stated disqualifier.",No,Cigna covers BRCA testing for individuals with personal or family histories suggestive of hereditary breast/ovarian (and related) cancer syndromes. This patient’s indication is congenital hearing/visual impairment and a sibling with an unexplained respiratory/altered responsiveness event — none meet Cigna’s BRCA medical indication criteria.,Not Specified,"Cigna BRCA coverage generally requires documentation of relevant personal/family cancer history; there is no payer requirement that specific prior genetic tests (beyond e.g., known familial mutation testing when applicable) must precede full BRCA sequencing in this scenario, and the provided prior FISH result is unrelated.",No,"Cigna’s BRCA family-history criteria require relatives with breast, ovarian, pancreatic, or related cancers. The provided family history (sibling with a brief resolved unexplained event) does not meet those specified family-history criteria.",Not Specified,"While genetic counseling is recommended in Cigna guidance for hereditary cancer testing, the policy's coverage decision is based on clinical indications; the provided information documents no pre-test counseling, but the policy language does not explicitly make documented pre-test counseling an absolute prerequisite for coverage in all cases.",Not Specified,None of the listed CPT options correspond to the usual BRCA1/BRCA2 sequencing CPT codes (which are typically in the 81211–81217 range). Therefore no provided code accurately maps to BRCA1/2 testing.,No,Applying Cigna BRCA coverage criteria: the patient lacks a personal or qualifying family history of BRCA‑related cancers and the clinical reason (hearing/visual impairment) is unrelated to hereditary breast/ovarian cancer — thus the test does not meet medical necessity criteria and is not covered.,1989,2309,4298
Case10529,baseline,without_policy,iter3,WES,The clinical note explicitly states whole exome sequencing (WES) is being pursued with UHC coverage.,Yes,"UHC WES criteria specify pediatric patients with unexplained developmental delay/intellectual disability are eligible; the patient is 6 years old, meeting pediatric age criteria.",Yes,"UHC requires ordering by an appropriate treating physician with documentation of genetics involvement; this case was referred by neurology and the family completed multiple sessions with a genetic counselor, satisfying ordering/provider requirements.",Yes,UHC defines unexplained developmental delay/intellectual disability as a medical indication for WES; the child has nonsyndromic developmental delay and intellectual disability.,No,UHC policy generally requires prior first‑tier testing (chromosomal microarray and Fragile X testing) before WES; Fragile X was nondiagnostic but there is no documentation that CMA was performed.,Yes,Family history of neurologic disease (maternal uncle with dystonia and ataxia) is present and is a relevant family-history element considered by UHC in evaluating genetic testing appropriateness.,Yes,UHC requires documentation of pre‑test genetic counseling for WES; the family has seen a genetic counselor multiple times and pre‑test counseling is complete with plans for post‑test follow‑up.,81415,CPT 81415 corresponds to clinical whole exome sequencing (proband or single‑sample exome) which matches the requested WES.,No,"Although age, indication, counseling, and ordering/provider involvement meet UHC criteria, required prior testing (chromosomal microarray) is not documented; UHC typically requires CMA prior to WES, so coverage would be denied pending completion/documentation of CMA.",1987,1288,3275
Case18821,baseline,without_policy,iter3,WES,The obstetrician explicitly requests fetal whole exome sequencing (WES) at 22 weeks to evaluate multiple congenital anomalies.,Not Specified,BCBS FEP genomic sequencing policies do not impose age limits for prenatal/fetal testing; no age-based exclusion applies to a 22‑week fetus.,Not Specified,The record shows an obstetrician ordered the test. BCBS FEP policies typically require a qualified ordering clinician but do not universally mandate a specific specialty in all cases; the case file does not state a payer-specific required ordering specialty.,Yes,BCBS FEP medical-necessity criteria for prenatal WES support testing when fetal imaging shows multiple congenital anomalies across organ systems and a genetic etiology is suspected to inform perinatal management—criteria met here.,No,BCBS FEP generally requires prior standard cytogenetic testing (karyotype/CMA) and/or targeted testing to be non-diagnostic before fetal WES; the patient has no prior genetic testing documented.,Yes,"There is a reported maternal aunt with dysmorphic features — a family history suggestive of a possible heritable syndrome, which is relevant to eligibility under BCBS FEP criteria that consider family history supportive of genetic testing.",No,BCBS FEP typically requires documentation of pre-test genetic counseling for genomic sequencing tests; there is no documentation of pre-test genetic counseling in the record.,81415,"CPT 81415 corresponds to exome sequencing (WES), which best matches the requested fetal whole exome sequencing.",No,"Although the clinical indication (multiple fetal anomalies) meets BCBS FEP medical-necessity criteria for prenatal WES, required prerequisites (documented pre-test genetic counseling and prior standard cytogenetic testing such as CMA/karyotype or targeted testing) are not documented; therefore coverage would be denied per BCBS FEP conditions.",1991,1771,3762
Case5230,baseline,without_policy,iter3,WES,The patient was referred for whole exome sequencing (WES) explicitly.,Not Specified,UHC WES coverage criteria do not set a strict age cutoff in most published guidance; the patient is a 15‑year‑old adolescent which would fall within typical pediatric eligibility but no explicit age restriction is specified.,Not Specified,UHC policies for WES focus on clinical indications and prior testing rather than requiring a specific ordering provider specialty in most cases; no specialist restriction is documented in the provided patient information.,Yes,UHC covers WES for individuals with unexplained congenital anomalies or neurodevelopmental disorders after standard testing is nondiagnostic; this patient has a congenital anomaly and meets that clinical indication.,Yes,UHC typically requires prior chromosomal microarray (CMA) testing to be nondiagnostic before WES; the record states a nondiagnostic CMA was performed.,Yes,"Family history can be relevant to WES eligibility; the patient has a sibling with an inborn error of metabolism, which is clinically relevant and supports testing per UHC criteria.",No,"UHC WES guidance requires documentation of pre‑test genetic counseling/informed consent; the patient declined genetic counseling, so the counseling requirement is not met.",81415,CPT 81415 corresponds to clinical exome sequencing (WES) interpretation/reporting and is the appropriate code for a proband WES request.,No,"Although clinical indication and prior testing (nondiagnostic CMA) are met and family history is supportive, UHC requires documentation of pre‑test genetic counseling/informed consent for WES; counseling was declined and therefore the counseling requirement is not met, resulting in noncoverage per payer criteria.",1953,2120,4073
Case6478,baseline,without_policy,iter3,BRCA1/2,Provider explicitly referred patient for germline BRCA1 and BRCA2 testing to inform therapy and cascade testing.,Not Specified,"UnitedHealthcare BRCA coverage is driven by clinical indications (e.g., personal history of relevant cancers) rather than a specific age cutoff; the 52-year-old patient's age does not conflict with typical policy age limits.",Not Specified,UHC policies generally allow ordering by a treating physician or qualified genetics provider; no specialty restriction for ordering BRCA testing is specified in the provided patient information.,Yes,"Patient has metastatic prostate cancer, which is an accepted medical indication for germline BRCA1/2 testing per UHC/NCCN-aligned coverage (and the family history of pancreatic cancer further supports testing).",Not Specified,"UHC BRCA coverage does not require prior genetic testing (e.g., tumor-only testing) as a universal prerequisite in this clinical scenario; no specific prior test completion is documented or required in the provided criteria.",Yes,"Family-history criteria are part of BRCA coverage rules and the patient reports a first-degree relative (father) with pancreatic cancer, a BRCA-associated malignancy that supports testing eligibility.",No,"UHC coverage for germline BRCA testing requires documentation of genetic counseling and informed consent; the patient did not receive pre-test genetic counseling (only plans for post-test counseling), so counseling requirement is not met.",81228,The requested test is germline BRCA1/2 sequencing; 81228 is the CPT listed here that corresponds to BRCA gene testing (selecting the BRCA-related CPT provided in the answer options).,No,"Although the patient meets clinical indications (metastatic prostate cancer and relevant family history), coverage requires documented pre-test genetic counseling; because pre-test counseling was not completed/documented, the request does not meet UHC's coverage procedural requirements and would be denied until counseling is documented.",1976,2229,4205
Case13613,baseline,without_policy,iter3,WES,Patient was referred for whole exome sequencing (WES) per the clinical note.,Not Specified,"UnitedHealthcare WES policies do not impose a strict chronological age cutoff; prenatal/fetal testing is considered under the clinical indications rather than an age limit, so no specific age-based exclusion applies.",Yes,"UHC WES coverage typically requires ordering/authorization by or in consultation with a genetics specialist; the record states pre-test discussion occurred with a genetic specialist, meeting the provider requirement.",Yes,"UHC indication for WES includes multiple congenital/structural anomalies or other unexplained major anomalies. Fetal imaging at 22 weeks identified multiple structural anomalies, which meets the medical indication.",No,"UHC generally requires prior standard testing (eg, chromosomal microarray) to be performed and nondiagnostic before WES for fetal structural anomalies. Only Fragile X testing is documented (nondiagnostic); CMA is not documented, so required prior testing is incomplete.",Yes,There is a reported family history of dysmorphic features in a maternal aunt; family history is present and potentially relevant under UHC criteria that consider family history supportive of testing.,Yes,"UHC requires documentation of genetic counseling or specialist discussion prior to WES; the record documents pre-test discussion with a genetic specialist, satisfying counseling requirements.",81415,CPT 81415 corresponds to clinical exome sequencing (WES) and is the appropriate code for the requested test.,No,"Although the clinical indication, ordering provider, and genetic counseling meet UHC criteria, a required prior test (chromosomal microarray) is not documented as completed and nondiagnostic. Per UHC policy, WES coverage is contingent on completion of required prior testing, so the request is not covered as submitted.",1978,1686,3664
Case5380,baseline,without_policy,iter3,WGS,The clinical note explicitly states whole genome sequencing (WGS) is requested to assess an underlying genetic cause.,Not Specified,"UnitedHealthcare WES/WGS coverage criteria do not impose a strict maximum/minimum age cutoff for testing; infants are eligible when clinical criteria are met, so no age-based exclusion applies to this 8‑week‑old.",Not Specified,"UHC policies require an appropriately credentialed ordering clinician but do not universally mandate a specific specialty; this test was ordered after neurology referral, which is an appropriate ordering provider under typical UHC practice.",Yes,UHC coverage allows WGS/WES for pediatric patients with unexplained neurologic presentations (recurrent seizure‑like events/BRUE) when a genetic etiology is suspected; this infant meets that clinical indication.,Yes,"UHC typically requires prior chromosomal microarray for developmental/ congenital/genetic presentations; CMA was performed and nondiagnostic as stated, satisfying this prior testing requirement for escalation to WGS.",No,"UHC criteria consider family history of a similar phenotype or consanguinity as relevant when present; the only family note is maternal short stature, which is not a reported family history of the infant's neurologic phenotype and thus does not meet family‑history eligibility criteria.",No,"UnitedHealthcare policies require documentation of pre‑test genetic counseling by a qualified clinician for high‑complexity genomic testing; the family explicitly declined pre‑test counseling, so this requirement is not met.",81425,The requested test is whole genome sequencing; CPT code 81425 corresponds to WGS (whole genome sequence analysis) and is the appropriate billing code.,No,"Although clinical indications and prior CMA are consistent with UHC coverage for WGS, the required pre‑test genetic counseling was declined and not documented. Per UHC coverage/billing rules, this unmet counseling requirement prevents coverage authorization.",1981,2668,4649
Case15570,baseline,without_policy,iter3,BRCA1/2,The clinician explicitly requested BRCA1 and BRCA2 testing despite the pediatric gastrointestinal indication.,Not Specified,FEP BRCA coverage is driven by personal/family cancer history and clinical indication rather than a strict age cutoff; no age-based eligibility criterion specific to BRCA testing is documented in the patient information.,Not Specified,The case does not document any payer-imposed ordering-provider specialty requirement; FEP policies typically allow ordering by the treating clinician and do not mandate a specific specialty in the provided information.,No,"FEP BRCA coverage requires a relevant personal history of breast/ovarian cancer or a family history meeting defined risk thresholds. This patient (age 15) has Hirschsprung disease, no personal cancer history, and no documented family cancer history, so does not meet the medical/clinical indications.",Not Specified,The provided FEP-related information does not indicate any required prior genetic testing (and the prior nondiagnostic karyotype is not a typical prerequisite for BRCA testing).,No,"Family-history criteria are relevant for BRCA coverage under FEP, but the only family history documented is a mother with bipolar disorder and no cancer history, so the patient does not meet family-history eligibility.",No,FEP BRCA testing generally requires documentation of pre-test genetic counseling or informed consent by a qualified provider; the record states there is no documentation of pre-test genetic counseling.,81277,"Among the provided CPT options, 81277 most closely corresponds to BRCA1/BRCA2 gene testing (the available choices do not include the more specific BRCA CPTs such as 81211/81213), so 81277 is the best match for BRCA1/2 testing in this list.",No,Per FEP BRCA coverage criteria the patient lacks qualifying personal or family cancer history and there is no documentation of required pre-test genetic counseling; therefore the requested BRCA1/2 test is not covered.,1979,2111,4090
Case5834,baseline,without_policy,iter3,CMA,The referral explicitly requests chromosomal microarray (CMA) testing to evaluate a genomic etiology for the patient's developmental disorder.,Not Specified,BCBS FEP CMA coverage is based on clinical indication (unexplained intellectual disability/developmental disorder) rather than an age cutoff; no specific age restriction is specified and the policy applies across ages.,Not Specified,BCBS FEP CMA criteria do not mandate a specific ordering provider specialty for coverage (ordering by treating clinician/genetics team is acceptable); the record shows neurology referral but no restrictive provider requirement is specified.,Yes,The patient has lifelong severe intellectual disability diagnosed by age 18 and is being evaluated for an unexplained developmental disorder — this meets BCBS FEP medical necessity indications for CMA as a first‑line test for unexplained intellectual disability/developmental delay.,Not Specified,"BCBS FEP generally considers CMA a first‑line test for unexplained intellectual disability and does not require prior genetic testing (e.g., karyotype) before performing CMA; no specific prior-test requirement is documented.",Not Specified,Family history criteria are not relevantly specified for CMA eligibility in BCBS FEP policy; the noted maternal ovarian cancer is not a criterion that affects CMA coverage for evaluation of developmental disability.,Yes,"BCBS FEP expects genetic counseling to be offered/documented for genomic testing; the patient had pre‑test counseling with a genetic counselor and post‑test follow‑up was planned, satisfying counseling requirements.",81415,CPT 81415 corresponds to chromosomal microarray (genomic copy number analysis) and is the appropriate code for CMA.,Yes,"Under BCBS FEP coverage criteria CMA is medically necessary for unexplained intellectual disability/developmental disorder; the patient meets the clinical indication, pre‑test counseling is documented, and no prior tests or restrictive provider requirements block coverage.",2002,1966,3968
Case1501,baseline,without_policy,iter3,WES,The clinical note explicitly states Whole Exome Sequencing (WES) is being ordered to identify an underlying genetic etiology.,Yes,UHC WES coverage is focused on pediatric patients with unexplained developmental delay/multiple congenital anomalies; the patient is 2 years old and therefore meets age-related pediatric eligibility.,Not Specified,"UHC policies for WES typically require an appropriate ordering clinician and documented genetic counseling but do not mandate a specific specialty (e.g., only a medical geneticist) as a hard ordering-provider restriction in the scenario provided.",Yes,"UHC covers WES for unexplained global developmental delay/ongoing developmental concerns and multiple congenital anomalies; the patient has both multiple congenital anomalies and developmental concerns with a nondiagnostic prior cytogenetic test, meeting clinical indication criteria.",No,"UHC generally requires prior appropriate testing (e.g., chromosomal microarray as first‑tier testing for developmental delay/multiple congenital anomalies). Only a nondiagnostic karyotype is reported; a CMA is not documented, so required prior testing has not been completed.",No,"Relevant family-history criteria for WES would be similarly affected relatives or known familial pathogenic variants; the only family history noted is maternal Long QT (cardiac), which is not documentation of a family history of the patient's developmental/structural phenotype and does not meet family-history eligibility criteria.",Yes,"UHC requires documentation of pre-test genetic counseling for WES; the record states pre-test genetic counseling was completed and post-test follow-up is planned, meeting counseling requirements.",81415,CPT 81415 corresponds to exome sequencing (WES) with interpretation and report and is the appropriate code for the ordered test.,No,"Although the patient meets age, clinical indication, and counseling requirements, UHC requires prior appropriate testing (notably chromosomal microarray) which is not documented. Because required prior testing was not completed, coverage would not be approved at this time.",1975,2171,4146
Case10427,baseline,without_policy,iter3,WGS,The clinical note explicitly states whole genome sequencing (WGS) is being requested to identify a potential genetic etiology.,Yes,UHC WES/WGS criteria apply to pediatric patients with unexplained neurodevelopmental or neurologic findings; the patient is an 8‑week‑old infant and therefore meets age‑based pediatric criteria.,Not Specified,"UHC policies require an appropriate ordering provider but do not universally limit ordering to a board‑certified geneticist; the record shows a neurologist referral (an appropriate specialist), but the policy does not strictly specify one single required specialty in this case.",Yes,The infant has significant unexplained hypotonia and a family history of an affected sibling with developmental regression—clinical indications accepted by UHC for WES/WGS in pediatric patients with suspected genetic neurologic disorders.,No,UHC typically requires prior relevant testing (at minimum chromosomal microarray and other indicated tests) to be nondiagnostic before WES/WGS except in certain ICU/critically ill neonatal situations; only FISH (nondiagnostic) was done and no CMA is documented.,Yes,"The family history includes an older sibling with unexplained developmental regression, which is relevant and supportive per UHC criteria for hereditary neurologic/developmental disorders.",Yes,"UHC requires informed consent/genetic counseling for WES/WGS; pre‑test counseling by a genetic counselor was completed multiple times and post‑test follow‑up is planned, satisfying counseling requirements.",81425,The requested test is whole genome sequencing; CPT 81425 corresponds to whole genome sequencing analysis and interpretation.,No,"Although age, clinical indication, family history, and counseling meet UHC criteria, required prior testing (notably chromosomal microarray or other recommended prior genetic tests) is not documented; per UHC policy this omission typically precludes coverage of outpatient WGS.",1993,1900,3893
Case8485,baseline,without_policy,iter3,WES,The patient information explicitly states whole exome sequencing (WES) has been ordered.,Not Specified,"Cigna WES coverage is driven by clinical indication rather than a strict age cutoff; no age-based exclusion is specified and an 8-year-old is within typical pediatric eligibility, but the policy does not state an age limit.",No,"Cigna’s WES policy requires ordering/authorization by an appropriate genetics specialist or documentation of genetics consultation (e.g., medical geneticist/genetic counselor or relevant specialist). The order was placed by a general pediatrician without documented genetics consultation, so ordering-provider requirements are not met.",Yes,"Cigna covers WES for individuals with unexplained developmental delay/neurologic findings or suspected Mendelian disorder; this child has hypotonia since infancy, persistent motor delay and evolving tone abnormalities consistent with a possible genetic etiology, meeting the medical indication criterion.",No,"Cigna typically requires prior relevant testing (at minimum chromosomal microarray and, where applicable, Fragile X). Fragile X was nondiagnostic but there is no documentation of prior chromosomal microarray testing, so required prior testing is incomplete.",Yes,"Family history is relevant to eligibility; the family reports a sibling with autism spectrum disorder, which is a pertinent neurodevelopmental family history that supports a genetic evaluation.",No,"Cigna’s WES policy requires documentation of pre-test genetic counseling by a qualified provider; the record states pre-test genetic counseling was not performed, so counseling requirements are unmet.",81415,CPT 81415 corresponds to whole exome sequencing (proband/exome sequencing) and best matches the ordered WES.,No,"Although the clinical indication is consistent with Cigna’s WES coverage criteria, coverage prerequisites are unmet: no documented chromosomal microarray prior testing, no pre-test genetic counseling, and the ordering provider/consultation requirements are not satisfied. Therefore the test as currently ordered would not meet Cigna coverage criteria.",1971,1790,3761
Case11795,baseline,without_policy,iter3,WES,The clinical note explicitly states 'whole exome sequencing (WES) is being ordered to evaluate for an underlying genetic cause.',Not Specified,"BCBS_FEP WES policy applies to patients of any age when clinical indications are met; there is no payer-imposed age cutoff in the policy, and the infant age (3 weeks) does not conflict with coverage criteria.",Not Specified,BCBS_FEP WES coverage requires an ordering clinician but does not universally restrict by a specific specialty in the policy text; the order from a cardiologist with documented pretest counseling meets typical ordering requirements and no specialty exclusion is specified.,Yes,"BCBS_FEP considers WES medically necessary for individuals with suspected genetic disorders after standard testing is nondiagnostic. The infant has a markedly abnormal ECG concerning for channelopathy/arrhythmia/cardiomyopathy and a nondiagnostic CMA, meeting the medical indication.",Yes,"The payer policy requires prior appropriate testing (e.g., chromosomal microarray) when indicated before WES; the record states CMA was previously performed and nondiagnostic, satisfying the prior-test requirement.",Yes,"Family history is relevant per coverage considerations; there is a sibling with moderate–severe intellectual disability diagnosed in childhood, which supports a genetic etiology and bolsters medical necessity.",Yes,BCBS_FEP typically requires documentation of pre-test genetic counseling for WES; the record documents that pre-test genetic counseling was completed with plans for post-test follow-up.,81415,"CPT 81415 corresponds to whole exome sequencing (proband only), which matches the requested WES in the clinical note.",Yes,"Under BCBS_FEP WES policy the patient meets coverage criteria: clinically suspected genetic disorder (abnormal ECG/possible channelopathy), prior CMA nondiagnostic, supportive family history, and documented pre-test counseling — therefore WES is covered.",2021,1453,3474
Case2007,baseline,without_policy,iter3,BRCA1/2,Patient was referred specifically for BRCA1 and BRCA2 testing (statement: 'referred ... for BRCA1 and BRCA2 testing').,Yes,"BCBS_FEP BRCA coverage includes age-based clinical indications (eg, personal history of breast cancer at a young age such as ≤50); the patient is 18 with breast cancer, which meets age-based eligibility.",Yes,BCBS_FEP allows ordering by the treating physician when appropriate documentation and genetic counseling are provided; the test was ordered by the family medicine physician and pre-test counseling was completed.,Yes,"Medical-necessity criteria for BRCA testing include personal history of breast cancer at a young age and/or first-degree relative with breast cancer ≤50; the patient has early-onset breast cancer and a mother with breast cancer ≤50, meeting criteria.",Not Specified,BCBS_FEP BRCA criteria do not require completion of specific prior diagnostic genetic tests (beyond documenting family history or known familial mutation); the prior CMA is noted but is not a required prior test for BRCA testing.,Yes,"Family-history criteria are relevant for BRCA testing and the patient has a first-degree relative (mother) with breast cancer at age 50 or younger, which is a specified relevant family-history criterion.",Yes,"BCBS_FEP generally requires documentation of genetic counseling for BRCA testing; the patient completed pre-test counseling and will return for post-test counseling, satisfying counseling requirements.",Not Specified,"The standard CPT codes for full BRCA1/2 sequencing (eg, legacy codes such as 81211/81213) are not listed among the provided options, so no direct mapping to the supplied CPT choices can be made with confidence.",Yes,"Based on BCBS_FEP coverage criteria: patient has personal early-onset breast cancer, relevant first-degree family history, documented pre-test counseling, and no unmet prior-test requirements — BRCA1/2 testing is covered.",1980,2368,4348
Case7297,baseline,without_policy,iter3,WES,Patient record explicitly states 'whole exome sequencing (WES) is being pursued.',Not Specified,UHC WES policy does not impose a strict age cutoff for exome sequencing; the patient is 3 years old and age-based exclusion/limit is not specified in coverage criteria.,Yes,"UHC generally requires testing be ordered by or in consultation with an appropriate genetics provider; pre-test counseling was completed with a genetic specialist and follow-up is planned, satisfying ordering/provider consultation requirements.",Yes,"UHC covers WES for individuals with unexplained multiple congenital anomalies affecting multiple organ systems after standard workup. The 3-year-old has multiple congenital anomalies across organ systems, meeting the medical indication.",No,"UHC policies typically require prior chromosomal microarray (CMA) as first‑tier testing for multiple congenital anomalies. The record notes a nondiagnostic karyotype but does not document a prior CMA, so required prior testing has not been completed.",No,"While family history of similarly affected relatives can be relevant per coverage guidance, the only family history reported is a maternal aunt with ovarian cancer which is not directly relevant to the child’s congenital anomaly indication; no consanguinity or affected relatives relevant to the child’s presentation are documented.",Yes,"UHC requires documentation of pre‑test genetic counseling for WES. The family completed pre‑test counseling with a genetic specialist and plans post‑test follow‑up, meeting counseling requirements.",81415,"CPT 81415 corresponds to clinical exome sequencing (WES) with interpretation and analysis, which matches the test requested.",No,"Although the patient meets medical indication and counseling/provider requirements for WES, UHC requires completion/documentation of prior chromosomal microarray (CMA) for multiple congenital anomalies; only a nondiagnostic karyotype is documented and no CMA result is provided, so coverage is not met at this time.",1997,1842,3839
Case2666,baseline,without_policy,iter3,BRCA1/2,The clinical note explicitly states the patient is undergoing BRCA1/2 testing at the request of her obstetrician.,Not Specified,"BCBS FEP BRCA policies do not impose a specific age cutoff for BRCA testing in adults; the patient is 21 (an adult), but the policy does not state an explicit age-based eligibility threshold.",Not Specified,"FEP policies generally allow ordering by the treating physician and do not narrowly restrict ordering to a specific specialty; the record shows an obstetrician ordered testing and pre-test counseling was completed, but the policy does not specify a unique ordering-provider requirement.",Yes,Medical indication: policy permits BRCA testing for unaffected individuals with a first-degree relative with a BRCA-associated cancer. A father with metastatic prostate cancer is a qualifying family history per FEP/NCCN-based criteria linking metastatic prostate cancer to hereditary BRCA-related risk.,Not Specified,"BCBS FEP BRCA coverage does not mandate prior diagnostic genetic tests (e.g., FISH) before BRCA1/2 sequencing; the prior nondiagnostic FISH is not listed as a required prior test.",Yes,Family history is relevant and present: a first-degree relative (father) with metastatic prostate cancer meets FEP criteria for familial indication for BRCA1/2 testing.,Yes,"FEP BRCA policies require pre-test genetic counseling; the patient completed pre-test counseling with a genetic specialist and has plans for post-test follow-up, satisfying counseling requirements.",81277,"Among the provided CPT options, 81277 corresponds to BRCA large rearrangement/duplication-deletion testing and is the closest code related to BRCA1/2 testing; full BRCA workup commonly includes sequencing plus rearrangement analysis.",Yes,"Based on FEP coverage criteria the patient is an unaffected adult with a first-degree relative (father) who has metastatic prostate cancer (a BRCA-associated cancer), pre-test genetic counseling was completed, and no disqualifying prior-test or provider issues exist — therefore BRCA1/2 testing is covered.",1980,2710,4690
Case13983,baseline,without_policy,iter3,WGS,"Patient information explicitly states ""whole genome sequencing (WGS) is being pursued.""",Yes,"BCBS_FEP WES/WGS criteria authorize testing for infants/children with suspected genetic disorders or critically ill neonates; the patient is a 7‑week‑old infant, which meets pediatric/infant age criteria for WGS.",Not Specified,BCBS_FEP policies emphasize appropriate ordering and genetic counseling but generally do not mandate a specific ordering specialty in all situations; the record documents pre‑test genetic counseling but does not indicate a payer requirement that only certain specialties may order WGS.,Yes,Medical necessity criteria for WGS/WES under BCBS_FEP include infants with a suspected genetic etiology for a significant clinical presentation. The infant has a high‑risk BRUE with a markedly abnormal ECG suggestive of channelopathy/arrhythmia/cardiomyopathy and family history — meeting a defined clinical indication for comprehensive genomic testing.,Not Specified,"BCBS_FEP allows WGS as first‑line in certain infants with strong suspicion for a monogenic disorder or complex presentation; while prior targeted testing (e.g., FISH/CMA/gene panels) may be appropriate in some cases, the policy does not universally require a specific prior test here. The record notes nondiagnostic FISH but no mandatory prior test requirement is documented.",Yes,Family history criteria (affected relatives with possible neurodevelopmental or unexplained regression) are relevant to WGS eligibility. The maternal uncle's unexplained developmental regression constitutes a positive family history supporting genetic evaluation.,Yes,"BCBS_FEP expects pre‑test genetic counseling for comprehensive genomic testing. The record states pre‑test counseling was completed with a genetic counselor and post‑test follow‑up is planned, satisfying counseling requirements.",81425,"Among the provided CPT options, 81425 most closely corresponds to whole genome sequencing/broad genomic sequencing services (WGS) used for comprehensive sequence analysis.",Yes,"Based on BCBS_FEP coverage criteria applied to this case: the patient is an infant with a significant clinical presentation (abnormal ECG and high‑risk BRUE), supportive family history, pre‑test genetic counseling completed, and prior targeted testing nondiagnostic. These factors meet medical necessity criteria for WGS, so the test is covered.",2045,2434,4479
Case15458,baseline,without_policy,iter3,BRCA1/2,The clinical note explicitly states the patient is being evaluated for BRCA1 and BRCA2 testing.,Not Specified,BCBS_FEP BRCA coverage criteria are driven by personal/family cancer history rather than a strict age cutoff; the record gives the patient age (19) but the policy does not impose an absolute age exclusion for germline BRCA testing.,Yes,"BCBS_FEP allows testing ordered by qualified treating clinicians; the order came from a nurse practitioner, which is an allowable ordering provider type under typical FEP policy when acting within scope of practice.",Yes,"Medical necessity criteria in the BCBS_FEP BRCA policy include a personal history of breast cancer and/or a family history of BRCA-associated cancers (ovarian, male prostate, etc.). The patient has a personal history of breast cancer plus a maternal aunt with ovarian cancer and a close relative with metastatic/intraductal prostate cancer, meeting indication criteria.",Not Specified,BCBS_FEP BRCA criteria do not mandate completion of a specific prior laboratory test (the prior nondiagnostic FISH is not a standard required precursor to germline BRCA testing).,Yes,"Family-history criteria are relevant for BRCA coverage; the patient has a maternal aunt with ovarian cancer and a close relative with prostate cancer, both BRCA-associated cancers that support testing per BCBS_FEP policy.",Yes,"BCBS_FEP typically requires documentation of pre-test genetic counseling for BRCA testing; the patient completed pre-test counseling and plans post-test follow-up, satisfying this requirement.",Not Specified,"The usual CPT codes for BRCA1 and BRCA2 full-gene sequencing (e.g., 81211, 81213) or for specific BRCA analyses are not among the provided options, so none of the listed codes clearly correspond to BRCA1/2 germline testing.",Yes,"Applying BCBS_FEP BRCA coverage rules: the patient has a personal history of breast cancer plus family members with ovarian and prostate cancers (BRCA-associated), completed pre-test counseling, and the test was ordered by an acceptable provider—thus medical necessity and administrative requirements are met and coverage is indicated.",1991,2282,4273
Case18868,baseline,without_policy,iter3,WGS,The clinical note explicitly states whole genome sequencing (WGS) has been ordered to assess for an underlying hereditary cancer predisposition.,Not Specified,Cigna WGS/WES policies typically define clinical-indication-based eligibility rather than strict age cutoffs for adults with cancer; no age-based eligibility criterion for WGS in this adult hereditary-cancer context is specified in the materials.,Not Specified,Cigna coverage rules for WGS do not universally require a specific ordering provider specialty in the documentation provided here; the record shows evaluation by a medical geneticist but the policy-level provider requirement is not specified in the supplied information.,No,"Cigna's coverage criteria for hereditary cancer testing favor guideline-based single-gene or multi-gene panels (e.g., BRCA/pan-cancer panels) for suspected hereditary cancer. WGS is generally not listed as an accepted diagnostic test for adult hereditary cancer predisposition; therefore the patient does not meet a listed medical indication for WGS under the payer's criteria.",No,"Cigna policies for hereditary cancer generally expect prior appropriate targeted testing (e.g., BRCA1/2 or multigene hereditary cancer panel) before broader investigational testing like WGS. The record states only a nondiagnostic karyotype and does not document prior guideline-based hereditary cancer panel or BRCA testing.",Not Specified,"While a family history of a hematologic disorder is reported, Cigna's WGS-specific criteria do not explicitly define family-history/consanguinity rules for adult cancer WGS in the provided materials; therefore family-history criteria for WGS are not specified here.",No,"Cigna frequently requires documentation of pre-test genetic counseling for advanced genomic testing such as WGS/WES; the provided materials explicitly note no documented pre-test genetic counseling, so counseling requirements (if applicable) are not met.",81425,"Among the CPT options provided, 81425 corresponds to whole genome sequencing (WGS) and is the appropriate code for the ordered test.",No,"Under Cigna coverage criteria, WGS in an adult with suspected hereditary cancer is not supported as first-line testing; guideline-directed targeted hereditary cancer testing (BRCA or multigene panel) is appropriate and prior testing/counseling are lacking. Therefore WGS would not be covered.",1989,2112,4101
Case10917,baseline,without_policy,iter3,WES,The case text explicitly states whole exome sequencing (WES) has been ordered to evaluate for an underlying genetic cause.,Not Specified,"UHC WES coverage criteria do not impose a strict age cutoff; policies apply to pediatric and adult indications but do not specify a disqualifying age for an 8‑week infant, so age-specific criteria are not specified.",Yes,"UHC requires that WES be ordered by an appropriate clinician and accompanied by specialist evaluation/counseling; this infant was evaluated and pre‑test counseling was completed by a medical geneticist/genetics specialist, meeting ordering/provider requirements.",Yes,"UHC medical necessity criteria support WES for suspected monogenic disorders and unexplained congenital anomalies; the patient has persistent conjugated hyperbilirubinemia, an affected sibling with multiple congenital anomalies, and WES was ordered to evaluate an underlying genetic cause, meeting clinical indications.",No,"UHC typically requires prior standard testing (e.g., chromosomal microarray for multiple congenital anomalies) before WES unless exceptions apply; Fragile X testing was done but chromosomal microarray or documentation of prior cytogenetic testing is not provided, so required prior testing is not documented.",Yes,"Family history criteria are relevant for WES; the patient has an older sibling with multiple congenital anomalies, which supports testing under UHC familial/phenotypic criteria.",Yes,"UHC requires documented pre‑test genetic counseling for WES; the record states pre‑test counseling was completed with a genetic specialist, satisfying counseling requirements.",81415,"CPT code 81415 corresponds to clinical exome sequencing (WES) with data analysis and interpretation, which matches the requested test.",No,"Although clinical indications, ordering provider, family history, and pre‑test counseling meet UHC criteria, a required prior test (chromosomal microarray/cytogenetic testing) is not documented. Because UHC generally requires prior CMA for multiple congenital anomalies before WES, coverage would likely be denied absent documentation of prior CMA or an allowed exception.",1984,1744,3728
Case12792,baseline,without_policy,iter3,BRCA1/2,The patient was explicitly referred for BRCA1/2 testing in the clinical information.,Not Specified,BCBS_FEP BRCA coverage is based on personal/family cancer history and clinical criteria rather than a strict age cutoff; no payer age-based exclusion for BRCA testing is specified in this case.,Not Specified,BCBS_FEP policy does not typically restrict BRCA testing to a specific ordering specialty (physicians or genetic counselors can order) and no provider-type limitation was provided in the patient data.,No,"BCBS_FEP BRCA coverage requires personal history of relevant cancers or a family history meeting defined high-risk criteria (e.g., multiple relatives with breast/ovarian cancer, early-onset disease). The 12-year-old has congenital choanal atresia and a non-specific maternal growth abnormality, which do not meet BCBS_FEP BRCA medical indications.",Not Specified,BCBS_FEP BRCA testing does not require prior cytogenetic tests such as FISH; the provided prior FISH result (nondiagnostic) is not a required antecedent test per the coverage criteria.,No,"BCBS_FEP BRCA eligibility depends on family history of breast/ovarian (or related) cancers; the only family history noted is a maternal 'growth abnormality,' which is not a qualifying family cancer history, so relevant family-history criteria are not met.",Yes,"BCBS_FEP requires documentation of pre-test counseling for BRCA testing; the record states pre-test genetic counseling was completed and post-test follow-up is planned, meeting counseling requirements.",81277,"Among the provided CPT options, 81277 is the molecular pathology-type code most consistent with BRCA1/2 gene testing (large rearrangement/diagnostic BRCA testing) — the exact BRCA sequencing CPTs (e.g., 81211/81213) are not listed in the choices.",No,"Applying BCBS_FEP BRCA coverage criteria, the patient lacks a qualifying personal or family cancer history despite having counseling; therefore BRCA1/2 testing is not covered for this clinical presentation.",1963,2210,4173
Case8710,baseline,without_policy,iter3,WES,The patient history explicitly states whole exome sequencing (WES) has been requested to investigate a genetic etiology for autism spectrum disorder with additional abnormalities.,Not Specified,"UnitedHealthcare WES coverage criteria do not impose a strict age cutoff; the clinical policy evaluates medical indication rather than an age threshold, and the patient is a pediatric case (12 y/o) which is within commonly covered age ranges but no explicit age limit is specified in the policy.",Not Specified,"UHC policies generally require an ordering clinician with appropriate expertise, but the policy does not rigidly limit ordering to a single specialty in all cases. The referral was from a developmental pediatrician (an appropriate specialist), but the policy language about an exact required ordering provider is not explicitly specified in the provided patient data.",Yes,"Clinically the patient has autism spectrum disorder plus at least one additional abnormality affecting another organ system and a nondiagnostic prior cytogenetic test, which meets common UHC medical indications for WES (neurodevelopmental disorder with additional anomalies suggesting an underlying genetic etiology).",No,"UHC WES coverage typically requires prior recommended testing (chromosomal microarray and/or Fragile X and other targeted tests as appropriate). The patient had a nondiagnostic karyotype but no documented chromosomal microarray (CMA) or other recommended prior tests, so required prior testing has not been completed.",Not Specified,"While a family history of neurologic disease (paternal uncle with dystonia/ataxia) is documented and may be clinically relevant, UHC WES criteria do not make specific family history or consanguinity a strict standalone eligibility requirement; the policy treats family history as supportive but not a defined gatekeeper criterion.",No,"UnitedHealthcare typically requires documentation of pre-test genetic counseling/informed consent for broad genomic tests like WES. The case states no pre-test genetic counseling was documented, so this required element is not met.",81415,CPT 81415 corresponds to exome sequencing (whole exome) and is the appropriate billing code for WES in this context.,No,"Although the patient meets clinical indication for WES, key UHC coverage prerequisites are unmet: required prior testing (e.g., CMA) is not documented and pre-test genetic counseling is not documented. Based on UHC policy requirements, coverage would be denied until those prerequisites/documentation are satisfied.",1991,1876,3867
Case16246,baseline,without_policy,iter3,BRCA1/2,The referral explicitly states BRCA1 and BRCA2 testing is being requested.,Yes,UHC hereditary cancer testing criteria include affected individuals with breast cancer diagnosed before age 50; the patient is 35 and therefore meets age-related eligibility.,Yes,"UHC requires ordering by a licensed provider/physician or qualified healthcare professional but does not restrict to a specific specialty; the test was ordered/referral placed by the patient's gynecologist, which meets ordering-provider requirements.",Yes,"Medical necessity criteria for BRCA testing include a personal history of breast cancer diagnosed <50 years; the patient has breast cancer diagnosed before age 50, meeting a defined clinical indication.",Not Specified,"UHC policy does not mandate completion of other genetic tests (the prior nondiagnostic karyotype is unrelated) as a prerequisite to BRCA1/2 sequencing, so no specific prior-test requirement is defined.",Yes,"Family-history criteria are part of BRCA eligibility rules; the patient reports an uncle with pancreatic cancer, which is a relevant family-history finding that supports hereditary cancer evaluation.",No,"UHC requires documentation of pre-test genetic counseling/informed consent for hereditary BRCA testing; the patient has had no pre-test genetic counseling, so counseling requirements are not met.",81228,"Of the provided CPT options, 81228 corresponds to BRCA1/BRCA2 hereditary breast/ovarian cancer gene testing (best match among choices).",No,"Although age and medical indication are met and the ordering provider is acceptable, UHC requires documentation of pre-test genetic counseling for BRCA testing and no counseling has been performed; without this required documentation, coverage would not be authorized.",1974,1798,3772
Case14017,baseline,without_policy,iter3,WES,The case text explicitly states 'whole exome sequencing (WES) has been ordered.',Not Specified,"BCBS FEP WES coverage policy does not impose an absolute age cutoff; WES is applied across ages. The patient is a 7‑week‑old infant, which does not conflict with age expectations for WES.",Not Specified,"BCBS FEP policies typically require an appropriate ordering clinician and documentation of counseling but do not universally restrict ordering to a single specialty; the record shows a pediatrician ordered testing and pre‑test counseling was completed, and the policy does not specify a prohibitive ordering‑provider requirement.",Yes,"BCBS FEP WES coverage supports testing for unexplained early‑onset neurologic presentations (recurrent seizure‑like events/BRUE) when a genetic etiology is suspected. The infant has recurrent witnessed seizure‑like events and a high‑risk BRUE, meeting the clinical indication.",No,"BCBS FEP criteria commonly expect prior appropriate cytogenomic testing (chromosomal microarray) or documentation why such testing is not informative before WES. The patient had a nondiagnostic conventional karyotype, but no CMA is reported, so a required prior test (CMA) has not been completed.",Yes,"Family history of neurologic disease (maternal uncle with movement disorder, dystonia and ataxia) is present and is a relevant supportive family history for a suspected genetic neurologic disorder per BCBS FEP criteria.",Yes,"BCBS FEP typically requires documentation of pre‑test genetic counseling for WES; the record documents that pre‑test counseling was completed with plans for post‑test follow‑up, meeting counseling requirements.",81415,The best corresponding CPT among the options for whole exome sequencing is 81415 (exome sequencing).,No,"Although the infant meets clinical indications and counseling and family history are documented, BCBS FEP coverage expectations include prior cytogenomic testing (chromosomal microarray) which has not been completed (only nondiagnostic karyotype reported). Because required prior testing is incomplete, coverage would not be approved at this time.",2004,1958,3962
Case5674,baseline,without_policy,iter3,WES,The team explicitly plans whole exome sequencing (WES) to investigate a possible genetic epilepsy syndrome.,Not Specified,BCBS FEP WES policies do not impose a strict age cutoff for exome sequencing; pediatric age is acceptable but the policy is not age-limited in the provided context.,Not Specified,The patient record shows GP involvement plus multiple genetic counseling visits and planned genetics follow-up. BCBS FEP policies commonly require specialist consultation or genetics involvement but do not universally restrict which clinician may sign the order; no explicit ordering-provider prohibition is stated in the provided information.,Yes,"BCBS FEP criteria support WES for suspected genetic epilepsy in a child with persistent seizures and nondiagnostic prior testing; here the child has persistent seizures and concern for a genetic epilepsy syndrome, fitting medical necessity criteria.",Yes,BCBS FEP typically requires prior chromosomal microarray (CMA) for unexplained neurodevelopmental/epilepsy presentations; the record documents a nondiagnostic CMA has already been completed.,Yes,Family history is relevant to testing criteria: an uncle with sudden unexplained death before age 35 supports suspicion for an inherited arrhythmia/epilepsy channelopathy and strengthens medical necessity per BCBS FEP guidance.,Yes,"BCBS FEP requires genetic counseling for clinical WES; the patient has had multiple visits with a genetic counselor and arrangements for post-test genetics follow-up, meeting counseling requirements.",81415,"The requested test is whole exome sequencing (proband exome), which corresponds to CPT code 81415 for exome sequencing with analysis and interpretation.",Yes,"Under BCBS FEP criteria, WES is medically indicated for a pediatric patient with persistent unexplained seizures, nondiagnostic CMA, relevant family history, and documented genetic counseling; these elements support coverage.",1978,1952,3930
Case9773,baseline,without_policy,iter3,CMA,The clinical note explicitly states a chromosomal microarray (CMA) was ordered to assess for genomic copy number changes in the child with severe intellectual disability.,Not Specified,BCBS FEP CMA coverage criteria use clinical indication (unexplained developmental delay/intellectual disability) rather than a strict age cutoff; no age-based exclusion is specified and a 2-year-old fits typical pediatric indications.,Not Specified,"FEP policies generally require an appropriate treating or ordering clinician but do not strictly limit CMA orders to a specific specialty; the record shows an MD specialist (oncologist) ordered the test, and payer policy does not explicitly restrict ordering provider type for CMA.",Yes,"Medical necessity criteria for BCBS FEP cover CMA as first‑line testing for unexplained intellectual disability/developmental delay; the patient is a 2‑year‑old with severe intellectual disability, meeting that indication.",Not Specified,"BCBS FEP treats CMA as a recommended first‑tier test for unexplained ID/DD, so no specific prior genetic testing (e.g., karyotype) is universally required prior to CMA; the record also indicates no prior genetic testing.",Not Specified,"Payer CMA criteria do not require a positive family history or consanguinity; although a maternal aunt has an immunologic disorder, that family history is not a specified required criterion for CMA coverage.",Yes,"BCBS FEP expects genetic counseling for high‑complexity genomic testing. The family completed pre‑test genetic counseling and plans post‑test counseling, satisfying counseling requirements.",81228,CPT 81228 corresponds to chromosomal microarray (constitutional microarray) testing for copy number analysis and is the appropriate code for the ordered CMA.,Yes,"Under BCBS FEP criteria, CMA is covered for individuals with unexplained intellectual disability/developmental delay. The 2‑year‑old has severe intellectual disability, no prior testing is required, pre‑test counseling is completed, and the order is from an appropriate treating clinician, so coverage is supported.",1994,1743,3737
Case18257,baseline,without_policy,iter3,BRCA1/2,The clinical note explicitly states the patient is being evaluated for BRCA1/2 testing to assess hereditary breast/ovarian cancer risk.,Yes,"Cigna criteria cover BRCA testing for individuals with a personal history of breast cancer diagnosed at age ≤50; the patient was diagnosed at age 50 or younger, satisfying the age-based criterion.",Yes,"Cigna generally requires an ordering clinician (licensed physician); the test was ordered by the patient's general practitioner (a physician), which meets typical provider ordering requirements.",Yes,Medical necessity criteria include a personal history of breast cancer diagnosed ≤50 as an indication for BRCA1/2 testing; the patient meets this specific indication.,Not Specified,Cigna's BRCA coverage criteria do not require completion of prior genetic tests (CMA was done but is unrelated); no specific prior-test prerequisite is documented in the policy for BRCA testing.,No,Family-history criteria for BRCA testing focus on relatives with breast/ovarian/pancreatic/prostate cancers; the only family history documented (sibling with short stature) is not relevant to BRCA eligibility.,No,"Cigna policy requires documentation of pre-test genetic counseling for hereditary cancer testing; there is no documentation of genetic counseling for this patient, so counseling requirements are not met.",81277,"Among the provided CPT options, 81277 most closely corresponds to BRCA1/BRCA2 genetic testing (sequence analysis/diagnostic assay for hereditary breast/ovarian cancer) per payer coding mappings.",No,"Although the patient meets age and medical-necessity criteria and the ordering provider is acceptable, Cigna requires documented pre-test genetic counseling for BRCA testing and no counseling is documented; therefore coverage would not be approved under the policy.",1976,2263,4239
Case10075,baseline,without_policy,iter3,CMA,The clinical note explicitly states consideration of chromosomal microarray (CMA) testing to evaluate for an underlying chromosomal or genetic etiology.,Not Specified,"BCBS_FEP CMA coverage criteria are indication-based (developmental delay, ID, ASD, multiple congenital anomalies) and do not impose a specific age limit; the infant's age (4 weeks) is not a disqualifying factor per payer criteria.",Not Specified,BCBS_FEP CMA coverage criteria do not mandate a particular ordering provider specialty beyond an authorized/credentialed clinician; the record documents pre-test counseling by a genetic specialist but the policy does not specify a unique ordering-provider requirement.,No,"Per BCBS_FEP coverage, CMA is medically indicated for unexplained developmental delay/ID, autism spectrum disorder, or multiple congenital anomalies. The infant has isolated meconium ileus and a family history of an inborn error of metabolism (a single-gene/metabolic concern), which do not clearly meet the payer's defined CMA indications.",Not Specified,"BCBS_FEP does not generally require specific prior testing before CMA; however, this patient already had a prior nondiagnostic CMA. Payer policy typically restricts repeat CMA unless new clinical findings are documented, but no required prior-test list is specified in the policy.",Not Specified,"While the patient has a family history of an inborn error of metabolism in a sibling, BCBS_FEP CMA eligibility is not driven by family history of single‑gene metabolic disorders; the policy does not specify family history/consanguinity criteria that would make CMA eligible in this scenario.",Yes,"BCBS_FEP expects appropriate pre-test genetic counseling/documentation for genomic tests; the record states pre-test counseling was completed with a genetic specialist and post-test follow-up was arranged, satisfying counseling requirements.",81277,"Among the provided code options, 81277 corresponds to chromosomal microarray/constitutional copy-number microarray testing (CMA) and best maps to the requested test.",No,"Applying BCBS_FEP coverage rules: CMA is covered for specific indications (DD/ID/ASD or multiple congenital anomalies). This infant has isolated meconium ileus and a family history of an inborn error of metabolism (single‑gene suspicion), and prior CMA was nondiagnostic. These facts do not meet the payer's defined medical necessity criteria for CMA or justify a repeat CMA, so coverage is not supported.",1991,3038,5029
